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Medical Aid in Dying by
Telehealth
Konstantin Tretyakov†
Abstract
Medical aid in dying is a form of medical treatment
recognized in several states and the District of Columbia and
available to adult residents of those states who are competent and
suffer from a terminal disease. Timely access to it is critical for
qualifying patients. The article explores the possibility of
facilitating access to medical aid in dying via telehealth—a
method of providing health care remotely by means of electronic
communication. Specifically, I analyze the feasibility of medical
aid in dying by telehealth from clinical and legal perspectives. I
also examine a relevant normative issue of the nature of in-person
medical examination and its relation to a valid doctor-patient
relationship. I conclude that while clinically medical aid in dying
can be provided to some qualifying patients, existing legal
restrictions make it problematic. I argue that to improve access
to medical aid in dying, we need to rethink what “in-person
medical examination” means in the digital age.
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Introduction
Imagine that a patient and his1 physician, who has already
been following the patient and monitoring his condition for
several months, each open a new smartphone application installed
on their phones. The app allows them to hear and see each other
using their devices’ microphones and high-resolution cameras.
When outfitted with various medical attachments, the app also
allows the patient to take his vital signs and send that
information directly to the physician. Both the physician and the
patient log into the app using passwords known only to them;
once secure connection is established and they are able to see and
hear each other in real time, the patient makes an oral request
for a certain medical treatment. The app’s dictation software
automatically uploads a transcript of the patient’s request to his
electronic-medical record (EMR). The doctor discusses the
request with the patient and asks him to submit certain
additional documents, such as a written request for the
treatment, the patient’s birth certificate, and proof of residency
in the state where the doctor is licensed to practice medicine.
After the patient uploads all of the necessary documents via
the app, his physician examines them and makes the patient’s
EMR accessible to his colleagues. This team of medical
1.

In this essay, I use the pronoun “she” to refer to a doctor and the
pronoun “he” to refer to her patient. This stylistic choice is for the
purpose of clarity only.
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professionals then determines whether the patient meets the
eligibility criteria to receive the requested treatment. In order to
do so, they consult the patient’s EMR and data from the app.
They ask him to take additional tests at a local provider’s office.
The results of those tests are then sent to the team for further
analysis. Upon completing the remote-evaluation process, the
team determines that the patient is eligible for the treatment.
The doctor then writes a prescription and mails the prescribed
medication to the patient.
The medication is a lethal dose of Secobarbital; the treatment
the patient has requested from his physician is medical aid in
dying (MAiD).2
MAiD, also known as physician-assisted death, death with
dignity, or physician-assisted “suicide,” is a medical treatment3
that is legally recognized and available to certain patients in
several states and in the District of Columbia.4 The treatment
consists of a physician prescribing to a qualifying patient a lethal
2.

See generally, Frequently Asked Questions, DEATH WITH DIGNITY,
https://www.deathwithdignity.org/faqs/ [https://perma.cc/4VBC
-8UFH] (last visited Oct. 13, 2019) [hereinafter Death with Dignity
FAQ].

3.

In this essay, I use the term “medical aid in dying” in the way it is
used in some of the statutes legalizing the practice. See, e.g., COLO.
REV. STAT. § 25-48-102 (West 2016). I do not use the unfortunate
and factually inaccurate term “physician-assisted suicide.” See
Morris v. Brandenburg, 376 P.3d 836, 842–43 (N.M. 2016)
(“[D]etailed expert testimony [submitted by proponents of
legalization of MAiD] explain[s] that the medical and psychological
professions do not consider a death from aid in dying to be a
suicide.”); Id. at 843 n.1 (explaining that “death from aid in dying
is not the same as a suicide. Suicide is typically brought on by a
‘psychiatric condition’ such as depression and is characteristically
an ‘impulsive’ and ‘solitary act.’ Accordingly, the family of a suicide
victim will usually experience ‘surprise, . . . shock and disbelief or
anger, a whole set of emotional reactions . . . reflecting a lack of
connection between the person who committed suicide’ and those
closest to that person. By contrast, aid in dying is characterized by
a ‘deliberative process,’ which ‘almost always involves the person
discussing [aid in dying] with [his or her] family and friends.’”)
(ellipses in original).

4.

See H.B. 2739, 29th Leg. (Haw. 2018) (stating that as of early 2018,
“five [other] states—Oregon, Washington, California, Vermont,
and Colorado—and the District of Columbia have passed legislation
to allow” MAiD); see also note 23, infra, discussing Montana’s
approach to MAiD.

327

Health Matrix·Volume 30·2020
Medical Aid in Dying by Telehealth

dose of medication that the patient can then self-administer.
Because MAiD can be provided legally only to patients suffering
from a terminal disease, it is critical that they have timely access
to it.5 Unfortunately, however, data suggest that a sizable
proportion of patients who lawfully request MAiD are not granted
access to the treatment because their condition declines shortly
after requesting MaiD and they die “naturally,”6 or they are no
longer capable to give informed consent to the treatment.7 There
is also evidence that some population groups have not received
MAiD at all.8

5.

Limited access to health care services is not, per se, a negative—in
fact, some restrictions on who can access certain limited resources
must be put in place to ensure a just rationing of those resources.
See generally, I. Glenn Cohen, Rationing Legal Services, 5 J. LEGAL
ANALYSIS 221 (2013) (comparing rationing principles applicable to
the allocation of legal services and medical care). But see Carter v.
Canada (Attorney General), 2015 SCC 5, 1 S.C.R. 343 (Can. 2015)
(“A person . . . [who is terminally ill] has two options: she can take
her own life prematurely, often by violent or dangerous means, or
she can suffer until she dies from natural causes. The choice is
cruel.”).

6.

See, e.g., Elizabeth T. Loggers et al., Implementing a Death with
Dignity Program at a Comprehensive Cancer Center, 368 NEW
ENG. J. MED. 1417, 1417 (2013) (noting that “26.3% [of patients]
initiated the process but either elected not to continue or died
before completion.”).

7.

Informed Consent: Code of Medical Ethics Opinion 2.1.1, AM.
MED. ASS’N, https://www.ama-assn.org/delivering-care/ethics/
informed-consent [https://perma.cc/P4HM-PXFN] (last visited
Dec. 20, 2019).

8.

Ronald A. Lindsay, Oregon’s Experience: Evaluating the Record, 9
AM. J. BIOETHICS 19, 22 (2009) (“The persons who have received
assistance in Oregon are overwhelmingly White (in fact, not one
African American has received assistance [in dying]) . . . .”); OR.
HEALTH AUTH’Y, OREGON DEATH WITH DIGNITY ACT 2017 DATA
SUMMARY 7 (2018), available at https://www.oregon.gov/oha/PH/
PROVIDERPARTNERRESOURCES/EVALUATION
RESEARCH/DEATHWITHDIGNITYACT/Documents/year20.p
df [https://perma.cc/WAF3-MC75] [hereinafter OR. 2017 DATA
SUMMARY] (noting that no patient who identified as black died from
MAiD in 2017 in Oregon); Accord CAL. DEP’T PUB. HEALTH,
CALIFORNIA END OF LIFE OPTION ACT 2017 DATA REPORT 6 (2018),
available at https://www.cdph.ca.gov/Programs/CHSI/CDPH
%20Document%20Library/2017EOLADataReport.pdf
[https://
perma.cc/F3XC-WL6M].
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There are a number of reasons why these patients’ access to
MAiD can be impeded. First and foremost, not all physicians in
the states where MAiD is available actually participate in MAiD,9
which diminishes the pool of available providers and restricts
access to MAiD. Second, MAiD is available only to the residents
of the states where it is legal.10 Third, the statutory waiting period
between requesting MAiD and receiving it can be further
extended due to the actual waiting times to schedule
appointments with available physicians and other medical
professionals who evaluate the patient’s eligibility for MAiD.
Fourth, like with many other medical treatments, not all patients
can bear the financial costs associated with MAiD.11 Finally,
potentially qualifying patients may be geographically located too
far from the providers who participate in MaiD.
One way to mitigate some of these impediments could be to
provide MAiD remotely by means of electronic communication:
that is, by telehealth. As summarized by Ray Dorsey and Eric
Topol, “[t]elehealth is the provision of health care remotely by
means of a variety of telecommunication tools, including
telephones, smartphones, and mobile wireless devices, with or
without a video connection.”12 Though discussing death via tele9.

See, e.g., Loggers et al., supra note 7, at 1419 (“Of 200 physicians
surveyed [at Seattle Cancer Care Alliance], 81 responded (40.5%, a
typical response rate for a general survey with no follow-up), with
29 physicians willing to act as a prescribing or consulting physician
(35.8%), 21 willing to act as a consulting physician only (25.9%),
and 31 unwilling to participate or undecided about participation
(38.3%).”).

10.

Death with Dignity FAQ, supra note 3.

11.

Id.

12.

In this essay, I use the word “telemedicine” (or its synonym,
“telehealth”) to denote the delivery of health care remotely by
means of electronic communication, including storing and
transmitting patients’ personal health information, remote
monitoring, live consultation, and asynchronous information
exchange. This definition comports with the way the terms
“telemedicine” and “telehealth” are defined in the states where
MAiD is now legal. One could argue that MAiD cannot fall under
the term telemedicine, because MAiD is designed to alleviate the
patient’s suffering and not to heal the patient. In this essay, I
stipulate that, since it has been recognized as a legitimate medical
treatment option—and undertaken with physician intervention—
in the states where it is legal, MAiD must fall within the ambit of
medicine and medical treatment options in those states. See E. Ray
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medical services may be controversial to some,13 as an emergent
and effective method for delivering care,14 its use for that purpose
may soon increase.
In early 2019, the legislature of Hawaii recognized
telemedicine’s potential to improve access to MAiD.15 And why
couldn’t it? Telehealth has proved to be efficient in increasing
access to other medical treatments, such as critical infant care.16
With telemedicine, patients who seek MAiD can more easily find
and connect with the doctors who provide it.17 Furthermore,
telemedicine can shorten waiting times between patient
appointments,18 which can critical on both a statutory and
practical level. Finally, because telemedicine providers can
quickly assemble a team of medical professionals to evaluate the
patient seeking MAiD, unlike medical professional who might be

Dorsey & Eric J. Topol, State of Telehealth, 375 NEW ENG. J. MED.
154, 154 (2016); HAW. REV. STAT. ANN. § 346−59.1 (2017)
(providing definitions for telemedicine and telehealth); See
generally Gonzales v. Oregon, 126 S.Ct. 904, 925 (2006) (holding
that it is up to each state to decide whether MAiD is a recognized
option of medical treatment).
13.

Julia Jacobs, Doctor on Video Screen Told a Man He Was Near
Death, Leaving Relatives Aghast, N.Y. TIMES (Mar. 9, 2019),
https://www.nytimes.com/2019/03/09/science/telemedicineethical-issues.html [https://perma.cc/G9WQ-BM6Q].

14.

Dorsey & Topol, supra note 13.

15.

Donna Clark, Medical Aid in Dying in the 50th State, ONCOLOGY
NURSING NEWS (Apr. 5, 2019), https://www.oncnursingnews.com/
contributor/donna-clark/2019/04/medical-aid-in-dying-in-the-50th
-state [https://perma.cc/3SK7-93KW].

16.

Jeremy M. Kahn, The Use and Misuse of ICU Telemedicine, 305
JAMA 2227 (2011) (discussing telemedicine aimed at “expanding
the reach and availability of intensivist clinicians” for neonatal
intensive-care units).

17.

Jeremy M. Kahn, Virtual Visits—Confronting the Challenges of
Telemedicine, 372 NEW ENG. J. MED. 1684, 1684 (2015) (“For
patients, telemedicine can reduce travel expenses and the
opportunity costs associated with obtaining care, such as missed
hours or days of work.”).

18.

How Telehealth Can Reduce Healthcare Wait and Travel Times,
INTOUCH HEALTH, https://intouchhealth.com/how-telehealth-canreduce-healthcare-wait-and-travel-times/
[https://perma.cc/
VWP6-TSY3] (last visited Dec. 20, 2019).
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confined to a brick and mortar office, it further improves access
to and the quality of treatment.19
While there is sizable literature on the separate topics of
MAiD and telemedicine, the discussion at their intersection is
significantly sparser,20 and this essay aims to narrow that gap.
The discussion on this topic is important not only because of its
obvious practical implications for patients and doctors who
request and provide MAiD, but also because it provides an
opportunity to reevaluate certain conventions about the doctorpatient relationship in the era of telehealth.
In this essay, I advance Hawaii’s initiative and analyze
whether or not it is clinically feasible to accomplish via telehealth
the other stages of the MAiD protocol—requesting the treatment,
evaluating the patient, and prescribing him with a lethal dose of
medication. I also examine the current legal frameworks for both
MAiD and telemedicine to see whether or not they allow for the
digitalization of MAiD. Lastly, I discuss several normative
implications of “tele-MAiD” and its impact on the burgeoning
MAiD field.
The argument unfolds as follows. First, I synthesize the
protocol for MAiD adopted in those states where the treatment
is legal. Roughly speaking, it consists of four main stages: (1)
request for MAiD; (2) evaluation of a potentially qualifying
patient; (3) dispensation of a lethal medication to the qualifying
patient; and (4) ingestion of that substance.
19.

That said, telemedicine is not a panacea against all problems that
restrict access to MAiD, such as high medication costs. See Taimie
Bryant, Aid in Dying: The Availability of Ideal Medications for Use
in “Right to Die” Jurisdictions in the United States, 34 QUINNIPIAC
L. REV. 705, 711–12 (2016) (“[T]he price for a lethal dose of liquid
sodium pentobarbital is $15,000–$25,000. The price for a lethal dose
of secobarbital, another barbiturate, has risen to $3,000–$5,000.”)
(footnotes omitted).

20.

For a notable exception, see Catharine J. Schiller, Medical
Assistance in Dying in Canada: Focus on Rural Communities, 13
J. NURSE PRAC. 628, 631 (2017) (mentioning that “the [Canadian]
legislation does not state that [assessments of eligibility for MAiD
and the prescribing process associated with MAiD] must be
performed in person. The decision of the federal government not to
include such a restriction meant that the possibility of using
telemedicine for this purpose remained open, an option that was
particularly important for rural and remote communities.”).
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Second, I explore the current state of telemedicine and argue
that for certain patients, from a clinical perspective, the first three
stages of the MAiD protocol can be completed remotely using
electronic means of communication: telehealth.
Third, I examine whether or not completing those stages via
telehealth involves heightened risks of legal liability for
participating providers. I consider the patients’ privacy, federal
and state regulation of medical devices, electronic prescriptions
for controlled substances, and state regulation of medical practice.
Fourth, I argue that the largest-legal obstacles to the
digitalization of MAiD concern the requirement that the doctor
conduct an “in-person” examination of the patient before
prescribing to him a controlled substance, such as Secobarbital.
This requirement stems from the traditional normative view of
the doctor-patient relationship, which I argue needs to be revised
to accommodate the evolving nature of that relationship in the
advent of telehealth.

I. Medical Aid in Dying Protocols in the United
States
As of January 2019, MAiD is legally available in the District
of Columbia and seven states—California, Colorado, Hawaii,
Oregon, Vermont, Washington,21 and Montana.22 In all of those
jurisdictions, providers who participate in MAiD follow the
protocol detailed in respective statutes, as well as the protocol
supplemented by individual state’s regulations.23 This Section I
21.

H.B. 2739, 29th Leg. (Haw. 2018) (stating that as of early 2018,
“five [other] states—Oregon, Washington, California, Vermont,
and Colorado—and the District of Columbia have passed legislation
to allow” MAiD).

22.

Strictly speaking, MAiD has not been legalized in Montana.
Instead, the Montana Supreme Court has recognized the statutory
defense of consent against criminal charges of homicide brought
against physicians who participated in MAiD that resulted in the
patient’s death. See Baxter v. State, 224 P.3d 1211, 1215 (Mont.
2009) (“The consent statute would shield physicians from homicide
liability if, with the patients’ consent, the physicians provide aid in
dying to terminally ill, mentally competent adult patients.”). For
ease of reference, however, I refer to Montana as a state in which
MAiD is “legal.”

23.

Montana physicians who offer MAiD to their patients appear to
follow the protocol adopted in other states. See Morris v.
Brandenburg, 376 P.3d 836, 855 (N.M. 2016) (explaining that a
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focuses primarily on the statutory requirements from which legal
liability for practicing MAiD via telemedicine may arise.
The components of MAiD are largely the same in
participating states. It is available only to the residents of that
state who: (1) are eighteen or older; (2) are capable of making
medical decisions; (3) seek MAiD voluntarily; and, (4) have an
irreversible, incurable disease that is likely to result in death in
six months or less within reasonable medical judgment (i.e. a
terminal disease).24 MAiD providers—an extensive team of
attending physicians, consulting (or second) physicians, mental
health specialist (psychologist, psychiatrist, or social worker), and
pharmacists—all must be licensed to practice medicine in that
state.25
The process of obtaining MAiD starts with the patient’s
request. For example, in California, the patient must make two
oral requests, separated by a fifteen to twenty-day waiting period,

physician who practices MAiD in Montana relies on the standard
of care set forth in the Oregon Death with Dignity Act); See
Loggers et al., supra note 7, at 1418 tbl. 1 (providing local
guidelines supplementing state requirements).
24.

CAL. HEALTH & SAFETY CODE § 443.1(q) (West 2018); COLO. REV.
STAT. § 25-48-103 (2018); D.C. CODE § 7-661.01(16) (2017); HAW.
REV. STAT. § 327L-1 (2019); OR. REV. STAT. § 127.800 (12) (2017);
VT. STAT. ANN. tit. 18, § 5281(10) (2015); WASH. REV. CODE
§ 70.245.010(13) (2009).

25.

Loggers et al., supra note 7, at 1419 (noting that, in practice, such
teams may include other specialists, for example patient
advocates). It also appears that in the vast majority of cases,
mental-health specialists do not participate in MAiD consultations.
OR. 2017 DATA SUMMARY, supra note 9, at 7 (“A total of 92
physicians wrote 218 prescriptions [for MAiD] during 2017. [5]
patients were referred for psychological or psychiatric evaluation.”);
WASH. ST. DEP’T HEALTH, 2017 DEATH WITH DIGNITY ACT REPORT
9
(2018), available at https://www.doh.wa.gov/Portals/1/
Documents/Pubs/422-109-DeathWithDignityAct2017.pdf [https://
perma.cc/4PRM-FNEF] [hereinafter WASH. 2017 REPORT] (noting
that 2% of patients who died from MAiD in 2017 were referred to
psychological or psychiatric evaluation); CTR. FOR HEALTH AND
ENVTL. DATA, COLO. DEP’T OF PUB. HEALTH AND ENV’T,
COLORADO END-OF-LIFE OPTIONS ACT, YEAR ONE 2017 DATA
SUMMARY 4 (2018) (providing that out of sixty patients
participating in MAiD in 2017, one has obtained mental health
provider’s confirmation).
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as well as one written request.26 The written request must be
made in the presence of two witnesses who certify that the patient
is mentally capable, is acting voluntarily, and is not being coerced
to sign the request.27 In addition, at least fifteen or twenty days
must pass between the first oral request and the dispensation of
the medication to the patient,28 and at least forty-eight hours
must pass between the written request and the dispensation of
medication.29 In California, the statute explicitly provides that
the request must be made “solely and directly by the individual
diagnosed with the terminal disease and shall not be made on
behalf of the patient.”30 Statutes in other states, while not
expressly forbidding the patient’s proxy to make a request on the
patient’s behalf, effectively impose the same restriction.31 The
patient can withdraw request for MAiD at any time.32
The patient first files his request with an attending
physician.33 Only one state, Vermont, requires that verbal
requests be made in the physical presence of an attending
physician; other states do not so specify.34 The patient’s attending
26.

CAL. HEALTH & SAFETY CODE § 443.3(a) (West 2018); HAW. REV.
STAT. ANN. § 327L-2 (2019) (requiring a waiting period of twenty
days); See, e.g., VT. STAT. ANN. tit. 18, §§ 5283(a)(1)−(4) (West
2015).

27.

CAL. HEALTH & SAFETY CODE §§ 443.3(b)(2), (3) (West 2018).

28.

See, e.g., CAL. HEALTH & SAFETY CODE § 443.3(a) (West 2018).

29.

See, e.g., CAL. HEALTH & SAFETY CODE § 443.5(a)(12) (West
2018).

30.

CAL. HEALTH & SAFETY CODE § 443.2(c) (West 2018).

31.

WASH. REV. CODE § 70.245.090 (2009) (“To receive a prescription
for [MAiD medication], a qualified patient shall have made an oral
request and a written request.”); COLO. REV. STAT. § 25-48-103(1)
(2018) (“An adult resident of Colorado may make a request . . . to
receive a prescription for [MAiD] medication . . . .”).

32.

CAL. HEALTH & SAFETY CODE § 443.3(a) (West 2018).

33.

CAL. HEALTH & SAFETY CODE § 443.3(b) (West 2018).

34.

Compare VT. STAT. ANN. tit. 18, §§ 5283(a)(1), (2) (West 2015)
(“The patient ma[kes] an oral request to the physician in the
physician’s physical presence for medication to be selfadministered for the purpose of hastening the patient’s death. No
fewer than 15 days after the first oral request, the patient made a
second oral request to the physician in the physician’s physical
presence . . . ”), with COLO. REV. STAT. § 25-48-104(1) (2018) (“In
order to receive a prescription for medical aid-in-dying medication
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physician is “a physician who has primary responsibility for the
care of a terminally ill individual and the treatment of the
individual’s terminal illness.”35 This suggests that the attending
physician and her patient may be in an existing doctor-patient
relationship when the patient requests MAiD, although there is
no express requirement that this must be the case.36
Upon receiving the patient’s request, the attending physician
must first confirm that the patient meets MAiD eligibility
requirements. The attending physician then informs the patient
about: (1) his diagnosis and prognosis; (2) the risks associated
with taking MAiD medications; (3) the results of taking that
medication; and, (4) alternative end-of-life care options, such as
palliative care, hospice care, and pain control.37 The attending
physician must inform the patient that he has the right to revoke
his MAiD request at any time and that he may elect not to take
the medication after receiving it.38 Other states require even more.
For example, Vermont’s statute provides that the attending
physician must base her medical evaluation of the patient on an
“in-person” examination.39
pursuant to this article, an individual who satisfies the
requirements [provided in the statute] must make two oral requests,
separated by at least fifteen days, and a valid written request to
his or her attending physician.”).
35.

COLO. REV. STAT. § 25-48-102(2) (2018).

36.

It bears noting that several statutes define “patient” as a person
“under the care of a physician.” E.g. WASH. REV. CODE
§ 70.245.010(9) (2009); D.C. CODE § 7-661.01(13) (2017).
Implicitly, this indicates that a patient seeking MAiD must have
an established relationship with a doctor; looking deeper, however,
these statutes do not specify that the relationship must exist
between the patient and the attending physician before the request
for MAiD is made. Indeed, some health care providers have
interpreted the relevant provision to be silent on whether the
doctor-patient relationship must predate the request for MAiD;
they have supplemented their MAiD protocols so that they
explicitly include that requirement. Loggers et al., supra note 7, at
1418 (noting that Seattle Cancer Care Alliance in the state of
Washington does not accept new patients solely for the purpose of
providing them with MAiD).

37.

WASH. REV. CODE § 70.245.040 (2009); COLO. REV. STAT. § 25-48106 (2018).

38.

CAL. HEALTH & SAFETY CODE § 443.5(a)(6) (West 2018).

39.

VT. STAT. ANN. tit., 18, § 5283(a)(5)(A) (West 2015).
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Additionally, the attending physician must also refer the
patient to a consulting physician who is tasked with examining
the patient and his medical record in order to (1) confirm the
patient’s diagnosis and prognosis, and (2) confirm that the
patient is capable of and, in fact is, making an informed,
voluntary decision to get the MAiD medication.40 If the attending
physician believes that the patient lacks the capacity necessary
to make an informed decision about MAiD, she must refer the
patient to a mental health specialist who can confirm that the
patient’s judgment is not impaired by a psychological or
psychiatric disorder or depression.41
If, after following these steps, the patient is found to meet the
statutory MAiD eligibility requirements, then the attending
physician must inform him about the logistics of the procedure
(including, but not limited, to the importance of notifying the
patient’s family, not taking the medication in a public place, and
not taking the medication alone), and must ensure, once again,
that the patient’s choice is free and informed.42 Following that,
the physician writes a prescription for a lethal dose of medication
(usually secobarbital, pentobarbital, or morphine sulfate43) and
can either dispense the medication to the patient directly, or, with
the patient’s consent, send the prescription to a pharmacist who
can then dispense the medication to the physician, the patient,
or the patient’s designee.44 At all stages of MAiD, the involved
medical professionals must carefully notate the aforementioned
steps in the patient’s medical record.45 The attending physician
must also notify the proper state governmental agencies
overseeing MAiD after writing a prescription for the medication.46
40.

WASH. REV. CODE § 70.245.040(1)(d) (2009); CAL. HEALTH &
SAFETY CODE § 443.5(a)(3) (West 2018).

41.

See, e.g., D.C. CODE § 7-661.04(a) (2017); OR. REV. STAT.
§ 127.825 (2017).

42.

See, e.g., COLO. REV. STAT. § 25-48-106(h)-(i) (2018); CAL. HEALTH
& SAFETY CODE § 443.5(a)(5) (West 2018).

43.

See, e.g., 21 C.F.R. §§ 1308.12(b), (e) (2018).

44.

VT. STAT. ANN. tit., 18, § 5283(a)(13) (2015); COLO. REV. STAT.
§ 25-48-106(k)-(l) (2018).

45.

See, e.g., WASH. REV. CODE § 70.245.120 (2009); D.C. CODE § 7661.06(a)(3)(E) (2017).

46.

See e.g., CAL. HEALTH & SAFETY CODE § 443.5(a)(11) (West 2018);
VT. STAT. ANN. tit., 18, § 5293 (2015).
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II. Providing Medical Aid in Dying by
Telemedicine Is Clinically Feasible
This Part II briefly describes the current state of telemedicine
and argues that it is clinically feasible, both for some patients
seeking MAiD and medical professionals providing it, to follow
the MAiD protocol through telehealth.
A. Current State of Telemedicine

As noted earlier, telehealth is the delivery of health care
remotely by means of electronic communication. Initially, the use
of telemedicine was limited to certain medical conditions (such as
a stroke or trauma) for patients who were in hospitals or satellite
clinics.47 Now, however, the reach of telemedicine has expanded.
Physicians are addressing an increasing number of conditions and,
in turn, reaching an increasing number of patients by telehealth
because it is a convenient and accessible health-care tool.48
With respect to the number of patients and providers who
use telehealth, its growth is largely attributable to the
proliferation of the internet and the increased integration of
smartphones into our lives.49 It was clear in 2016 that “[w]ith
increasingly available broadband and portable diagnostic
technologies, telehealth is rapidly moving to the home.”50 This
tendency shows no signs of slowing down, as smartphones play a
leading role in increasing access to telehealth.51 Indeed, by some
estimates, “[b]y 2018 . . . 65 percent of interactions with
healthcare facilities will occur with mobile devices. [Furthermore,]
80 percent of doctors already use smartphones and medical apps
in their practice.”52 Smartphones feature new and rapidly evolving
47.

Dorsey & Topol, supra note 13, at 154–155.

48.

Id.

49.

Id.

50.

Id.

51.

See, e.g., Mary E. Reed et al., Real-Time Patient-Provider Video
Telemedicine Integrated with Clinical Care, 379 NEW ENG. J. MED.
1478, 1478 (2018) (indicating that of the 210,383 studied video
visits “accessible through [i]nternet-connected, video-enabled
mobile devices or computers” scheduled from 2015 through 2017,
“[p]atients used smartphones for 74% of video visits, desktop
computers for 20%, and tablets for 6% . . . .”).

52.

Quora, What Are The Latest Trends In Telemedicine In 2018?,
FORBES (July 31, 2018, 3:38 PM), https://www.forbes.com/sites/
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technology; accordingly, they enable doctors not only to see and
hear their patients through microphones and high-resolution
cameras, but also to measure the patients’ heartbeat or even
potentially perform ultrasound scanning.53
Telehealth applications to various medical conditions also
have increased. Importantly, telemedicine has become
increasingly more accessible to patients with chronic conditions,
such as chronic obstructive lung disease and heart disease, which
can become terminal.54 Telehealth has also proven to be an
efficient and effective method of psychological counseling. For
example, the American Psychiatric Association has found that
“[t]elepsychiatry is equivalent to in-person care in diagnostic
accuracy, treatment effectiveness, quality of care[,] and patient
satisfaction. Patient privacy and confidentiality are equivalent to
in-person care.”55
quora/2018/07/31/what-are-the-latest-trends-in-telemedicine-in2018 [https://perma.cc/B4D9-ADGP] (presenting the findings of
the University of Texas School of Biomedical Informatics).
53.

University of British Columbia, Breakthrough Opens Door to
Smartphone-Powered $100 Ultrasound Machine, SCIENCE DAILY
(Sept. 11, 2018), https://www.sciencedaily.com/releases/2018/
09/180911110232.htm [https://perma.cc/48BT-B2NG] (discussing
the invention of a portable ultrasound scanner that can be powered
by a smartphone).

54.

AGENCY FOR HEALTHCARE RES. AND QUALITY, TELEHEALTH:
MAPPING THE EVIDENCE FOR PATIENT OUTCOMES FROM
SYSTEMATIC REVIEWS iv (2016), available at https://
effectivehealthcare.ahrq.gov/topics/telehealth/technical-brief
[https://perma.cc/GJ99-HUAK] (“The most consistent benefit has
been reported when telehealth is used for communication and
counseling or remote monitoring in chronic conditions such as
cardiovascular and respiratory disease, with improvements in
outcomes such as mortality, quality of life, and reductions in
hospital admissions. Given sufficient evidence of effectiveness for
these topics, the focus of future research should shift to
implementation and practice-based research.”); The Future of
Healthcare: Telehealth. Here’s Why You Need to Consider
Telemedicine in 2019, CONTINUING EDUC. J., https://
aceaglobal.com/continuing-education-journal/medical-insights/
the-future-of-healthcare-telehealth-heres-why-you-need-toconsider-telemedicine-in-2019/ [https://perma.cc/W3CN-UEFL]
(last visited Feb. 11, 2020).

55.

What Is Telepsychiatry?, AM. PSYCHIATRIC ASS’N (Jan. 2017),
https://www.psychiatry.org/patients-families/what-istelepsychiatry [https://perma.cc/G4U3-LMFA].
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Finally, it is important to keep in mind that the migration of
telehealth from hospitals to patients’ homes is but one tendency
in a broader trend of proliferation of information technology into
health care.56 Other tendencies include the digitalization of
patients’ medical records and secure cloud storage of patients’
data.57 These tendencies reinforce each other, making the presence
of telemedicine more prominent in our lives and urging us to
realize its potential more fully by creating new medical
treatments that utilize telehealth. One such treatment is MAiD.
B. Requesting MAiD

Using analogies to currently marketed smartphone apps and
technologies, we can readily imagine what MAiD by telehealth
could look like. A patient seeking MAiD could file a request for
the treatment on a smartphone application, provided that there
is a secure Wi-Fi or cellular-data connection between the patient
and the attending physician that allows them to identify each
other.58 Both the patient and the attending physician could use
the smartphone’s screen, virtual keyboard, camera, microphone,
and voice recognition technology to file both verbal and written
requests for MAiD. For example, a patient could dictate his
request to seek MAiD to the smartphone, which could use its
speech-dictation technology to transcribe the request59 and use his
56.

Health Information Technology Integration, AGENCY FOR
HEALTHCARE RES. & QUALITY, https://www.ahrq.gov/ncepcr/
tools/health-it/index.html [https://perma.cc/9M25-Q3Z7] (last
updated Aug. 2019).

57.

Shourjya Sanyal, 5 Surprising Ways in Which Telemedicine Is
Revolutionizing Healthcare, FORBES (Oct. 31, 2018), https://www.
forbes.com/sites/shourjyasanyal/2018/10/31/5-surprising-ways-inwhich-telemedicine-is-revolutionizing-healthcare [http://perma.cc/
L8NQ-DSKG].

58.

Encrypted connection can be established, for example, between the
patient’s and the doctor’s smartphones, and Tele-MAiD could be
password-protected (the password can be given to the patient and
the doctor via email by the doctor’s medical institution); it could
also use face-recognition technology or fingerprint scanning,
available on smartphones, for additional security. Cf. Elizabeth
O’Dowd, Telehealth Video Consults Affect Health IT
Infrastructure, HIT INFRASTRUCTURE (Jan. 8, 2018), https://
hitinfrastructure.com/news/telehealth-video-consults-affecthealth-it-infrastructure [https://perma.cc/S2CM-NERJ].

59.

See generally Bjorn Carey, Smartphone Speech Recognition is
Faster and More Accurate Than Typing, STAN. ENGINEERING (Aug.

339

Health Matrix·Volume 30·2020
Medical Aid in Dying by Telehealth

fingerprint to digitally “sign” it.60 After that, the app could send
the recording of the patient’s request to a server (for oral
requests) and then fill in the written request form as required by
statute using the transcription of the patient’s request,61 and send
the form to the server from where the attending physician could
download it. Additionally, the form could be made available to
others, such as statutorily required witnesses,62 to certify the
patient’s written request. Those individuals could either log in to
the app using their credentials set up by the patient or the
patient’s attending physician, or they could install and use the
app on their smartphones.63
Additionally, the app could be set up to remind the patient
to file the second oral request with the attending physician or
about the possibility to rescind the request at any time.64 All data
collected through the app could be encrypted and securely stored
on a server hosted by the attending physician’s hospital or a
third-party—this kind of record storage is standard in other areas
of medical practice.65 It is also worth noting that multiple
25, 2016), https://engineering.stanford.edu/magazine/article/
smartphone-speech-recognition-faster-and-more-accurate-typing
[https://perma.cc/4ZXJ-PKJ8].
60.

See generally Robert Triggs, How Fingerprint Scanners Work:
Optical, Capacitive, and Ultrasonic Variants Explained, ANDROID
AUTHORITY (Mar. 28, 2019), https://www.androidauthority.com/
how-fingerprint-scanners-work-670934/ [https://perma.cc/3UXF2PMN].

61.

See, e.g., OR. REV. STAT. § 127.897 (2017); CAL. HEALTH & SAFETY
CODE § 443.11 (West 2018).

62.

See, e.g., OR. REV. STAT. § 127.805 (2018); CAL. HEALTH & SAFETY
CODE § 443.2 (West 2018); D.C. CODE § 7-661.03 (2017); N.J. REV.
STAT. § 26:16-4 (2019); HAW. REV. STAT. § 327L-2 (2019).

63.

See generally Rachel Z. Arndt, There’s an App for That: Clinicians
are Using Apps to Improve Care, MOD. HEALTHCARE (Dec. 9,
2017),
https://www.modernhealthcare.com/article/20171209/
TRANSFORMATION03/171209903/there-s-an-app-for-thatclinicians-are-using-apps-to-improve-care
[https://perma.cc/
2NPP-Q53M].

64.

Seneca Perri-Moore et al., Automated Alerts and Reminders
Targeting Patients: A Review of the Literature, 99 PATIENT EDUC.
CONS. 953 (June 2016).

65.

“Teladoc” is a patient portal and an app that connects patients
and doctors in real time by video and phone calls. See, e.g., Teladoc
Privacy Policy, TELADOC, http://teladochealth.com.s3-website-us-
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applications already exist for interactions between doctors and
patients;66 perhaps their functionality could be extended to
accommodate requests for MAiD.
C. Evaluating the Patient

State statutes effectively control how medical providers must
evaluate a patient who requests MAiD.67 The providers who make
those determinations are the patient’s attending physician,
consulting physician, and mental health specialist.68 The issue of
using telemedicine in evaluating the patient turns on whether or
not providers can make their determinations about the patient
remotely using electronic communication.
Determining a patient’s age and residency status could be
easily verified via telehealth. For example, the patient could scan
or upload a digital copy of his birth certificate or passport to the
app to prove that he is an adult.69 Likewise, to prove his
residency, the patient could provide the attending physician with
either: (1) a copy of his driver’s license; (2) electronic copies of
tax returns filed in the state where MAiD is sought; (3) a copy of
documents establishing that the patient owns or leases real
east-1.amazonaws.com/en/privacy-policy/
5A9M-Z7J9] (last visited Feb. 18, 2020).

[https://perma.cc/

66.

Laura Landro, Doctors Prescribe New Apps to Manage Medical
Conditions, WALL ST. J. (Nov. 9, 2016), https://www.wsj.com/
articles/doctors-prescribe-new-apps-to-manage-medical-conditions1447094444 [https://perma.cc/6AS2-UEXH] (“Hospitals are
developing new mobile apps to help patients manage serious
medical conditions and feed information back to their doctors
between visits, often in real time.”).

67.

Patients must generally: (1) have a terminal illness; (2) be an adult
competent to make medical decisions; (3) be a resident of the state
where MAiD is sought; and (4) and make the decision to seek MAiD
voluntarily. See, OR. REV. STAT. § 127.805 (2018); CAL. HEALTH &
SAFETY CODE § 443.2 (West 2018); D.C. CODE § 7-661.03 (2017);
N.J. REV. STAT. § 26:16-4 (2019); HAW. REV. STAT. § 327L-2
(2019).

68.

See, e.g., OR. REV. STAT. § 127.805 (2018); CAL. HEALTH & SAFETY
CODE § 443.2 (West 2018); D.C. CODE § 7-661.03 (2017); N.J. REV.
STAT. § 26:16-4 (2019); HAW. REV. STAT. § 327L-2 (2019).

69.

See Key Benefits of Mobile Scanning for Healthcare Teams,
SCANDIT (Aug. 8, 2018), https://www.scandit.com/blog/keybenefits-of-mobile-scanning-for-healthcare-teams/ [https://perma
.cc/JH7L-NKDG].
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property in that state; or (4) the voter’s registration documents.70
In order to prevent identity fraud, the attending physician would
download the documents and verify whether or not the
information presented in those documents is accurate in the same
way that she would if the documents were presented in hard
copies.71
Determining the patient’s competency and the voluntariness
of his request involves consultations between the patient and the
attending physician (or, with the physician’s referral, between the
patient and a mental-health specialist). During those
consultations, the physician or the mental-health specialist
determine whether or not the patient has the capacity to make
an informed decision about MAiD.72 The attending physician
must also determine whether the patient’s request is voluntary—
that is, whether or not the patient is being coerced into requesting
MAiD.73
Nothing inherent to MAiD—or the current use of telehealth—
indicates that telehealth is ill-suited to such requirements.
Although studies have not addressed the accuracy of assessing
voluntariness to receive MAiD over telehealth, other studies
indicate that the providers’ ability to evaluate the voluntariness
of the patient’s request and the patient’s competency over

70.

For example, AirBnB, a peer-to-peer lodging network, requires its
users to upload various forms of identification to AirBnB’s server
so that AirBnB may verify the user’s identification and run
background checks. Airbnb ID Verification FAQ: How It Works
for Hosts and Guests, IGMS (Apr. 17, 2018), https://
www.igms.com/airbnb-id-verification/ [https://perma.cc/FU9UWKGS].

71.

E.g., Jenny Gold, Coming to a Doctor’s Office Near You: Photo
ID Check, KAISER HEALTH NEWS (July 29, 2009),
https://khn.org/news/medical-id/ [https://perma.cc/M528-84V4]
(explaining how doctors can fight identity theft); See Fighting
Identity Theft with the Red Flags Rule: A How-To Guide for
Business, FED. TRADE COMM’N, https://www.ftc.gov/tips-advice/
business-center/guidance/fighting-identity-theft-red-flags-rulehow-guide-business [https://perma.cc/68TT-5TBQ] (last visited
Feb. 18, 2020).

72.

Andrew Collins & Brendan Leier, Can Medical Assistance in Dying
Harm Rural and Remote Palliative Care in Canada?, 63 CAN. FAM.
PHYSICIAN, 186, 189 (Mar. 2017).

73.

Id.
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telehealth is materially similar to a face-to-face evaluation.74 For
doctors who routinely use telemedicine in their medical practice,
there would be little to no change at all; they could use the
camera and microphone of the smartphone to evaluate the
patient’s mental-health condition and any indicia of coercion.
Finally, one must consider whether it is possible to remotely
diagnose the patient requesting MAiD with a terminal disease.
According to the available data, most patients who qualify for
MAiD and terminate their lives through it are at the terminal
stage of cancer, amyotrophic lateral sclerosis (ALS),
heart/circulatory disease, or chronic obstructive pulmonary
disease (COPD).75 The manufacturers of smartphonetelemedicine apps claim that their products can accurately
diagnose at least some of those conditions using the technical
features of mobile devices and artificial intelligence,76 which allows
for the potential to use telemedicine in diagnosing a patient
requesting MAiD with terminal conditions. While there remains
a need of enhanced evidence to substantiate these claims,77 there
74.

Id.

75.

See, e.g., OR. 2017 DATA SUMMARY, supra note 9, at 6 (providing
that 76.9% of patients in Oregon who died ingesting MAiD
medication suffered from cancer, 7% had ALS, 6,3% had a
heart/circulatory disease); VT. DEP’T HEALTH, REPORT
CONCERNING PATIENT CHOICE AT THE END OF LIFE 4 (2018),
available at https://legislature.vermont.gov/assets/LegislativeReports/2018-Patient-Choice-Legislative-Report-12-1417.pdf
[https://perma.cc/32UN-NQA9 ] (noting that between May 31,
2013, and June 30, 2017, eighty-three percent of patients who died
from ingesting MAiD medication in Vermont had cancer and
fourteen percent had ALS); WASH. 2017 REPORT, supra note 26, at
6 (noting that seventy-two percent of the patients in Washington
who died in 2017 after ingesting MAiD medication had cancer,
eight percent had a neurodegenerative disease (including ALS),
nine percent suffered from a respiratory disease (including COPD),
and eight percent had heart disease).

76.

See, e.g., Michael Goodman, ResApp Brings Remote Diagnosis of
Respiratory Disease Via Mobile App, DIAGNOSTICS WORLD (Sept.
23, 2016), http://www.diagnosticsworldnews.com/2016/09/23/
resapp-brings-remote-diagnosis-of-respiratory-disease-via-mobileapp.aspx [https://perma.cc/5UJK-9T24] (discussing a mobile
application “developed to diagnose a wide range of conditions,
including lower respiratory tract diseases such as . . . [chronic
obstructive pulmonary disease].”).

77.

Reed V. Tuckson et al, Telehealth, 377 NEW ENG. J. MED. 1585,
1586 (2017) (noting “an urgency for enhancing the evidence for
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are at least three other factors that could weight in favor of the
use of telemedicine in this area.
First, there is substantive data suggesting that telemedicine
is an effective way of remotely monitoring patients with chronic
conditions.78 Accordingly, there are reasons to believe that
monitoring the patients with chronic conditions such as ALS,
heart disease, or COPD (which can ultimately lead to diagnosing
them with a terminal stage of those diseases) is clinically feasible,
especially if medical schools teach their students to use these new
telemedicine tools.79
Second, to enhance the quality of diagnostics, the patients
requesting MAiD may take the necessary tests in local clinics and
send the results to attending and consulting physicians.80 Based
on the information, the patient’s medical record, and their
personal observations of the patient, physicians can diagnose their

telehealth technology applications as clinicians and consumers
expand their use in numerous areas,” including management of
chronic diseases); See also Stephen O. Agboola et al., Digital Health
and Patient’s Safety, 315 JAMA 1697, 1698 (2016) (“When care is
delivered at distance, physicians and other clinicians may not
detect subtle cues that they could detect in person.”).
78.

Annette M. Totten et al., Telehealth: Mapping the Evidence for
Patient Outcomes from Systematic Reviews, 26 AGENCY FOR
HEALTHCARE RES. AND QUALITY vi (June 2016).

79.

Cf. Colette DeJong et al., Incorporating a New Technology While
Doing No Harm, Virtually, 314 JAMA 2351, 2351 (2015)
(“Physicians have long equated the physical examination with
laying on of hands, but much evaluation can be done virtually—for
example, by watching patients walk as a functional strength
examination. Physicians can be trained to assess a patient through
clinical mediators, such as a nurse who positions an electronic
stethoscope to transmit heart sounds. Standardized patient
encounters using telemedicine platforms could allow trainees to
practice remote evaluation and manage difficult discussions, such
as counseling an uninsured patient to seek emergency care for
dyspnea despite the cost.”).

80.

See, e.g., Heather Mack, Doctor on Demand to add lab-testing
services to their telemedicine platform, MOBI HEALTH NEWS (May
3,
2017),
https://www.mobihealthnews.com/content/doctordemand-add-lab-testing-services-their-telemedicine-platform
[https://perma.cc/G7E8-QCUS].
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patients with a terminal disease.81 Conceivably, some of the
qualifying patients’ tests already are analyzed remotely.82
Third, attending physicians who are in an already existingphysician-patient relationship will have the necessary context to
easily address the patient’s condition via remote diagnostics.83
This is especially true for physicians who have had multiple
opportunities to follow the patient before he requests MAiD.
Indeed, studies have demonstrated that long term doctor-patient
relationship can improve the accuracy of diagnostics.84
In sum, from a clinical perspective, one could argue that the
prospect of establishing the patient’s compliance with both formal
and clinical criteria for MAiD appear promising. This is especially
true with respect to validating the formal requirements, the
patient’s capabilities, and voluntariness. As to remotely
diagnosing terminal diseases, more data is required about the
reliability of smartphones and their apps in that respect.
However, there conceivably could be terminal conditions that the
doctors could accurately diagnose through telemedicine,
especially where the doctors have been following the patient’s
condition prior to the request for MAiD and where the doctors
know how to use the diagnostic tools that telemedicine offers.
D. Providing Patients with Medication

The final aspect of MAiD is dispensing the medication. In
many circumstances, a physician can dispense medication directly
81.

See id.

82.

For example, diagnosing a potentially qualifying patient with
terminal cancer can involve taking X-ray images of the patient’s
body. Those images can be sent by internet to a radiologist located
outside of the attending physician’s hospital for interpretation (the
practice known as teleradiology). Teleradiology, AM. C.
RADIOLOGY,
https://www.acr.org/Advocacy-and-Economics/
Legislative-Issues/Teleradiology [https://perma.cc/5XCZ-JCVM]
(last visited Oct. 13, 2019).

83.

See AM. MED. ASS’N, AMA CODE OF MEDICAL ETHICS OPINIONS ON
PATIENT-PHYSICIAN RELATIONSHIPS, available at https://www.
ama-assn.org/sites/ama-assn.org/files/corp/media-browser/codeof-medical-ethics-chapter-1.pdf
[https://perma.cc/BRR9-CS8S]
(last visited Sept. 27, 2019) (explaining that remote sensing and
monitoring devices can “enhance the efficiency and quality of care”
in already existing physician-patient relationships).

84.

R. Kaba & P. Sooriakumaran, The Evolution of the Doctor-Patient
Relationship, 5 INTL. J. SURGERY 57 (2007).
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to her patient or the patient’s representative during an office
visit.85 The attending physician can write an electronic
prescription for medication, as long as the prescription verifiably
has been issued by the attending physician on behalf of a qualified
patient.86 In the latter case, a pharmacist would dispense the
medication.87 After the prescription is written and sent to a
pharmacist, the patient could either pick up the prescription “in
person” or the drug could be delivered to the patient by mail.88
All of these steps provide the qualifying patient with the MAiD
medication, at which point the patient can decide whether or not
to take it.
In conclusion, from a clinical standpoint, all relevant stages
of MAiD protocol outlined in the statutes—patient requesting
MAiD, patient’s evaluation, and dispensation of MAiD drug to
patient—can be completed by telemedicine for patients whose
terminal conditions can be diagnosed remotely. Next, I consider
whether medical professionals who decide to use telemedicine for
MAiD incur higher risks of legal liability by doing so.

85.

See Matthew Grissinger, Good Intentions, Uncertain Outcomes:
Physician Dispensing in Offices and Clinics, 40 PHARMACY &
THERAPEUTICS 620 (2015).

86.

How Death with Dignity Laws Work, DEATH WITH DIGNITY,
https://www.deathwithdignity.org/learn/access/
[https://perma.cc/Q9WD-RCR5] (last visited Feb. 19, 2020)
(providing that electronic delivery of the prescription is acceptable
in California, Colorado, Hawaii, Maine, New Jersey, and D.C.).

87.

See, e.g., Arnold J. Rosoff, On Being a Physician in the Electronic
Age: Peering into the Mists at Point-&-Click Medicine, 46 ST.
LOUIS U. L. J. 111, 129 (2002) (“[T]he healthcare system in the
United States is clearly moving toward establishing electronic links
between physicians and pharmacists to facilitate ordering and
dispensing prescription drugs more efficiently and safely.”).

88.

Laura Daily, Should You Switch to a Mail-Order Pharmacy? Here
are the Factors to Consider, WASH. POST (Jan. 8, 2019),
https://www.washingtonpost.com/lifestyle/home/should-youswitch-to-a-mail-order-pharmacy-here-are-the-factors-to-consider/
2019/01/07/8b56f87a-0ede-11e9-8938-5898adc28fa2_story.html
[https://perma.cc/ES5M-N8JG].
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III. Legal Aspects of Providing Medical Aid in
Dying by Telehealth
An analysis of whether or not there are legal obstacles for a
medical professional to follow the protocol for MAiD via
telehealth is the necessary next step in this discussion. For
purposes of this analysis and discussion, it is to be assumed that
the medical professionals providing MAiD and the patient
requesting it are both in the same state and that they are both
using the app described in Part I. Let’s call the app “Tele-MAiD.”
There exist four broad areas of healthcare law over which the
issue of legality of telemedicine in MAiD, and Tele-MAiD span:
(1) protection of the patients’ privacy; (2) regulation of medical
devices; (3) dispensation of controlled substances; and (4)
regulation of the practice of medicine in general.89
A. Privacy of Patients

Patient’s privacy in the context of providing MAiD via
telemedicine has two intertwined aspects: (1) confidentiality of
the patient’s medical records and (2) confidentiality of the
patient’s communication with medical professionals involved in
the process.90 Both aspects are regulated by federal and state law.
If the patient and his attending physician, consulting
physician, and mental health specialist follow MAiD protocol
when using Tele-MAiD, such use will necessarily create part of
the patient’s electronic medical record. For MAiD, the content of
a patient’s EMR is the same as the content of the medical records
specified in the state statutes. That content must include: (1) all
oral and written requests for MAiD; (2) the attending physician
and consulting physician’s diagnosis, prognosis, and verification
that the patient is capable, acting voluntarily, and is making an
89.

I focus here on the telehealth-specific aspects of MAiD, leaving
aside the general liability issues (such as dispensing a wrong
medication to the patient and facing medical malpractice liability
claims). Such claims may arise in the context of providing MAiD
both via telemedicine and by conventional means—as they do in
all medical settings. For the same reason, I also assume that TeleMAiD enables doctors to adequately evaluate a patient’s eligibility
for MAiD so that the higher risk of medical-malpractice claims
against those medical professionals does not arise.

90.

Andrey Ostashko, HIPAA Requires Certain Measures for HER
Confidentiality, PROGNOCIS (Sept. 9, 2013), https://prognocis
.com/emr-confidentiality/ [https://perma.cc/K6KY-DVC9].
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informed decision; (3) the mental health specialist’s report and
conclusions if a referral was made; (4) the attending physician’s
offer to the patient to withdraw request for MAiD; (5) the
attending physician’s certification that all statutory requirements
have been met; and (6) the attending physician’s notation about
the steps taken for prescribing MAiD medication.91 If all stages of
MAiD are completed via Tele-MAiD, then the patient’s EMR also
would consist of the patient’s vital signs and other information
about her condition obtained or transferred via smartphone, as
well as all of the patient’s communication with the MAiD team
of medical professionals assigned to his case.92
The content of the EMR created via Tele-MAiD falls under
the definition of “health information” as provided in the federal
law regulating patients’ privacy—the Health Insurance
Portability and Accountability Act (HIPAA).93 HIPAA defines
health information as
any information, whether oral or recorded in any form or
medium, that is created or received by a health care
provider . . . and relates to the past, present, or future
physical or mental health or condition of an individual, the
provision of health care to an individual, or the past,
present, or future payment for the provision of health care
to an individual.94

HIPAA requires the Secretary of Health and Human Services
to issue national standards of protection of patients’ health
information, including requirements for the security of that
91.

OR. REV. STAT. § 127.855 (2017); WASH. REV. CODE § 70.245.120
(2009); VT. STAT. ANN. tit. 18, § 5283 (2015); CAL. HEALTH &
SAFETY CODE § 443.8 (West 2016); COLO. REV. STAT. § 25-48-111
(2018); D.C. CODE § 7-661.06 (2017). For example, in Vermont, the
attending physician must also certify that the patient was either
enrolled in hospice care or was informed about hospice care. VT.
STAT. ANN. tit. 18, § 113 (2015). Relatedly, the District of
Columbia statute specifically requires the attending physician to
document the patient’s residency. D.C. LAW, § 21-182 (2016).

92.

What is an Electronic Health Record?, HEALTH IT, https://
www.healthit.gov/faq/what-electronic-health-record-ehr [https://
perma.cc/AN74-6ZDN] (last visited Oct. 13, 2019).

93.

See Health Insurance Portability and Accountability Act of 1996,
Pub. L. No. 104-191, 110 Stat. 1936 (1996).

94.

42 U.S.C. § 1320d(4) (2018).

348

Health Matrix·Volume 30·2020
Medical Aid in Dying by Telehealth

information stored in electronic format.95 Those standards are
codified in the Privacy Rule and the Security Rule.96 The rules
require covered entities and their business associates to: (1) adopt
and implement privacy policies; (2) train their personnel to
comply with those policies; (3) secure patients’ records containing
personally identifiable health information; (4) ensure the
confidentiality, integrity, and availability of the patient’s health
information created, received, stored, or transmitted by covered
entities and business associates; and (5) protect that information
against being hacked and disclosed to third parties without
authorization.97
Conceivably, creating the EMR for a patient requesting TeleMAiD will not impose on covered entities a higher burden to
protect the patient’s protected information than what providers
already bear under the familiar requirements of federal law. Nor
will it require significant additional investments in the alreadyexisting infrastructure of maintaining the patient’s medical
records electronically. Generally speaking, it appears that much
(if not all) of the content of MAiD patient’s medical record
described in the state statutes may already exist in electronic
form, especially in large hospitals where MAiD has been made
available to qualifying patients.98 Additionally, many healthcare
providers already use various apps to receive, store, and transmit
personal health information of their patients, and adding TeleMAiD to that pool of resources and data will not change how the
standards of privacy and security should be and are
95.

42 U.S.C. § 1320d-1 (2018).

96.

45 C.F.R. §§ 160, 164 (2018). The Rules were most recently
amended to reflect the changes introduced by another federal
statute, the Health Information Technology for Economic and
Clinical Health Act (the HITECH Act), which can be found in Title
XIII, Division A, and in Title IV, Division B, of the American
Recovery and Reinvestment Act, Pub. L. No. 111-5, 123 Stat. 115
(2009). Those changes were introduced to ensure that HIPAA
standards of privacy and security were applicable not only to
“covered entities”—health care providers, health plans, and health
care clearinghouses—but also to their business associates
(organizations or individuals to whom covered entities outsource
their health care-related functions). Id.

97.

See generally U.S. DEP’T HEALTH & HUM. SERV., HIPAA
ADMINISTRATIVE SIMPLIFICATION REGULATION TEXT: 45 CFR
PARTS 160, 162, AND 164 (2013).

98.

HEALTH IT, supra note 93.
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implemented.99 This means that health care providers, as well as
other covered entities and business associates, largely already
comply with federal regulations regarding the privacy and
security of the personal health information of patients who seek
and obtain MAiD.100
From the perspective of state law, the consequences of
creating, transferring, and storing the EMRs of patients who seek
(and potentially receive) MAiD appear to be two-fold as far as
the exchange of the patients’ data is concerned. First, if the
servers―devices or programs that enable data exchanges―are
located within the state where MAiD is provided and the patient’s
EMR does not leave the territory of the state, then there appears
to be no additional privacy issues. This is so because the state
laws that authorize MAiD do not prohibit creating EMRs of
patients who receive or seek to receive MAiD.101 Similarly,
medical providers operating in those states likewise do not face
heightened privacy-protection requirements for MAiD patients
compared to other patients, so the privacy of whose medical data
they must maintain under applicable state laws remain
unchanged. Furthermore, the existence of an app, like TeleMAiD, that improves access to MAiD can also facilitate
compliance with recording requirements. For example, requests
for MAiD could be sent through Tele-MAiD as electronic files
(with voice or text), which could be securely stored in the doctor’s
hospital or a third party’s server.102 The same is true about
99.

Nathan Cortez, The Mobile Health Revolution, 47 U.C.D. L. REV.
1173, 1177 (2014) (“[M]obile health apps can link smartphones to
hundreds of hospital monitors, allowing physicians to track patient
vital signs remotely. Some apps allow physicians and patients to
view CT scans, MRIs, PET scans, and other medical images
remotely.”).

100. See Numbers at a Glance, HEALTH & HUM. SERV. (Aug. 31, 2019),
https://www.hhs.gov/hipaa/for-professionals/complianceenforcement/data/numbers-glance/index.html [https://perma.cc/
4CUY-9NFB] (demonstrating that most HIPAA complaints are
voluntarily resolved).
101. See, e.g., CAL. HEALTH & SAFETY CODE § 443.1(q) (West 2018);
COLO. REV. STAT. § 25-48-103 (2018); D.C. CODE § 7-661.01(16)
(2017); HAW. REV. STAT. § 327L-1 (2019); OR. REV. STAT.
§ 127.800 (12) (2017); VT. STAT. ANN. tit. 18, § 5281(10) (2015);
WASH. REV. CODE § 70.245.010(13) (2009).
102. See Nate Lord, Data Protection: Data In transit vs. Data At Rest,
DATAINSIDER: DIGITAL GUARDIAN’S BLOG (July 15, 2019),
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communication between the patient and medical professionals on
the MAiD team: all such communication would be recorded by
Tele-MAiD’s servers and, as such, form a part of the patient’s
EMR.103
If data servers are located in another state where MAiD is
not legal, the situation might be different. In that scenario, any
data created in electronic communication between the patient
and the doctor would “travel”104 between the state where MAiD
is legal to a server that may or may not be in a state where MAiD
is prohibited, and then back to physician. In that scenario, the
data constituting the patient’s EMR would also be stored on a
server outside of the state where MAiD is legal.
This dépeçage of data (and applicable state law) does not
seem to expose the providers of MAiD to additional liability for
violating privacy laws; after all, the state statutes authorizing
MAiD do not specify that relevant medical records must be kept
within those states.105 One could argue that enabling
MAiD−related communication between doctors and patients and
storing the patients’ EMRs might expose server providers to
additional liability, conceivably on the grounds of either engaging
in an unauthorized medical practice or being accomplices to
“aiding and abetting suicide”106 under the laws of a state where

https://digitalguardian.com/blog/data-protection-data-in-transitvs-data-at-rest [https://perma.cc/N5J5-FDXS].
103. See Elena Muller, The Role of Electronic Medical Records in
Telehealth, HEALTH RECOVERY SOLS., https://www.health
recoverysolutions.com/blog/the-role-of-electronic-medical-recordsin-telehealth [https://perma.cc/37WL-CG9V] (last visited Sept.
20, 2019).
104. I use “travel” to illustrate the process of the patient’s app
transmitting data from its location, Tele-MAiD’s server processing
the data in its location, and the server transmitting the data to the
doctor’s smartphone—wherever they each may be.
105. While MAiD statutes contain medical-record-documentation
requirements, the statutes fail to specify where such documentation
needs to be stored. See e.g. OR. REV. STAT. § 127.855 § 3.09 (2017);
COLO. REV. STAT. § 25-48-111 (2016).
106. See Robert Rivas, Survey of State Laws Against Assisting in a
Suicide, http://www.finalexitnetwork.org/Survey_of_State_Laws
_Against_Assisting_in_a_Suicide_2019_update.pdf
[https://
perma.cc/E2CP-H7XF] (last visited Feb. 18, 2020).
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their servers are located and where MAiD is a crime.107 Both
arguments, however, are unavailing. First, storing patients’ data
and enabling their communication with doctors is no more the
practice of medicine than is building a hospital: while both
activities make medical practice possible, neither constitutes
diagnosing, treating, or prescribing a medical condition. Second,
a state generally cannot prosecute conduct that occurs outside of
its borders.108 A limited exception to that general rule is the socalled “effects doctrine,” pursuant to which “[a]cts done outside
a jurisdiction, but intended to produce and producing detrimental
effects within it, justify a state in punishing the cause of the
harm.”109 Putting aside the issue of whether enabling MAiD in
the state where it is legal from the server state constitutes a crime,
such enabling produces no effects in the server state, and therefore
cannot claim criminal jurisdiction over server providers on that
ground. To avoid this problem altogether, it would be better for
the server providers to keep their equipment enabling digital
access to MAiD in the state where MAiD is legal, although this
could be problematic to implement from a technical standpoint.
This demonstrates that access to Tele-MAiD for qualifying
patients does not impose higher risks associated with the
protection of the patients’ privacy than those the covered entities
already face. At the same time, transferring patients’ data across
state lines might catch the eye of particularly zealous state law
enforcement authorities, although the risk of actual criminal
prosecution on those grounds appears to be low.
B. Medical Devices

Tele-MAiD is very likely to be considered a medical device,
because it is a “component, part, or accessory [of a smartphone
on which it is installed], which is . . . intended for use in the
diagnosis of disease or other conditions . . . .”110 Under the current
107. Take Action in Your State, DEATH WITH DIGNITY, https://www.
deathwithdignity.org/take-action/
[https://perma.cc/W5CT4DG5] (last updated Oct. 11, 2019).
108. In re Vasquez, 705 N.E.2d 606, 610 (Mass. 1999) (“The general
rule, accepted as ‘axiomatic’ by the courts in this country, is that
a [s]tate may not prosecute an individual for a crime committed
outside its boundaries.”).
109. Strassheim v. Daily, 221 U.S. 280, 285 (1911).
110. 21 U.S.C. § 321(h) (2018) (referencing the intended capacity of a
medical device to treat a disease, which does not apply to Tele-
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regulatory framework, all medical devices (including apps) are
divided into three classes based on their functionality intended
by their manufacturers and developers. The classification is based
on the degree of the risk that the intended functionality of a
device entails: low (class one), moderate (class two), and high
(class three).111 This classification is significant for purposes of
regulating the devices by the federal Food and Drug
Administration (FDA). While medical devices from the first class
receive very little oversight from the FDA, and devices from the
second class require manufacturer’s premarket notification
reviewed and generally accepted by the FDA,112 medical devices
from the third class, which “present[] a potential unreasonable
risk of illness or injury,” require the FDA’s premarket approval.113
If the FDA grants its approval, then it typically does so only after
the creator has endured long and costly clinical trials.114
At first blush, it may appear that Tele-MAiD belongs to the
third class of medical devices; after all, it “presents a potentially
unreasonable risk of illness and injury” because of the chance of
remotely misdiagnosing the patient with a terminal disease. If
that is true, then the developers of Tele-MAiD must obtain the
FDA’s premarket approval before disseminating their product
among doctors and patients.115

MAiD because that treatment is not directed to any particular
disease or medical condition—it is rather a means for the patient
to die with dignity).
111. Cortez, supra note 100, at 1201 (discussing the classification of
medical devices and its application to apps); See also FOOD & DRUG
ADMIN., MOBILE MEDICAL APPLICATIONS: GUIDANCE FOR INDUSTRY
AND FOOD AND DRUG ADMINISTRATION STAFF 13 (2015), available
at
https://research.unc.edu/files/2016/10/Mobile-MedicalApplications-FDA-Guidance-9-25-2013.pdf
[https://perma.cc/
D926-XRFS] [hereinafter MOBILE MEDICAL APPS].
112. Cortez, supra note 100, at 1201–1202.
113. 21 U.S.C. § 360c(a)(1)(C)(II) (2018).
114. See JOSH MAKOWER ET AL., FDA IMPACT ON U.S. MEDICAL
TECHNOLOGY INNOVATION: A SURVEY OF OVER 200 MEDICAL
TECHNOLOGY COMPANIES (Nov. 2010), available at https://www.
advamed.org/sites/default/files/resource/30_10_11_10_2010
_Study_CAgenda_makowerreportfinal.pdf
[https://perma.cc/
HX2V-5BYT].
115. 21 U.S.C. § 360c(a)(1)(C)(II) (2018).
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At the same time, it is important to keep in mind the FDA’s
“functional” approach to regulating medical devices, including
apps.116 In this respect, the determination of a class to which TeleMAiD could belong requires parsing the functionality of that
program. Those functions could include: (1) creating, storing, and
transmitting the patient’s medical record, including requests for
treatment and test results; (2) taking the patient’s vital signs;
and (3) real-time consultations between the patient and the team
of medical professionals evaluating his eligibility for MAiD.117 In
light of this limited functionality of the app, it appears more
appropriate to place it under the second class of medical
devices.118 Those devices, as mentioned earlier, require a notice of
intent to market them, filed with the FDA before they are offered
to the public.
There are two other things to bear in mind about the FDA’s
regulation of apps. First, as of 2019, the agency has not issued a
final rule on this issue. Instead, it has published guidance, which
“represents [the FDA’s] current thinking on the topic [and] does

116. MOBILE MEDICAL APPS, supra note 112, at 4 (“Consistent with the
FDA’s existing oversight approach that considers functionality
rather than platform, the FDA intends to apply its regulatory
oversight to only those mobile apps that are medical devices and
whose functionality could pose a risk to a patient’s safety if the
mobile app were to not function as intended.”).
117. It is important to underscore again that in proffering Tele-MAiD,
I do not purport that it would, or even could, automatize the
process of diagnosing patients with a terminal condition; it would
simply aid physicians in that endeavor. See MAKOWER ET AL., supra
note 115, at 27.
118. See, Examples of Pre-Market Submissions that Include MMAs
Cleared or Approved By FDA, U.S. FOOD & DRUG ADMIN. (Sept.
26, 2019), https://www.fda.gov/MedicalDevices/DigitalHealth/
MobileMedicalApplications/ucm368784.htm
[https://perma.cc/
GP9G-CZXY] (providing the list of mobile medical apps cleared or
approved by FDA, where only two apps—both of which appear to
be connected with an invasive glucose sensor system—have received
premarket approval, with all other apps cleared by FDA through
the notice-of-intent process); See also 21 U.S.C. § 360j(o) (2018)
(excluding from the definition of “medical device” certain
“decisions support software,” including the software intended “to
serve as electronic patient records, including patient-provided
information” and “for administrative support of a health care
facility, including . . . appointment schedules . . . ”).
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not operate to bind FDA or the public.”119 The agency’s “wait
and see” approach120 arguably facilitates the dissemination of apps
and is conducive to improving access of qualifying patients to
MAiD through telemedicine.121 Second, as the FDA has explained,
its rules implementing the standards for safety of medical devices
apply to app developers, not app users.122 In this respect, it would
be an odd result for doctors and patients to face adverse legal
consequences for using the app.
The FDA, however, is not the only agency that regulates apps
used for medical purposes. Two other agencies—the Federal
Trade Commission (FTC) and the Federal Communications
Commission (FCC)—also exercise gatekeeping functions in
regulating the app marketplace.123 Under the Federal Trade
Commission Act,124 the developers of the app cannot make
deceptive or misleading claims to consumers and that the app
must not do “more harm than good.”125 Should the issue of using
119. MOBILE MEDICAL APPS, supra note 112, at 4.
120. Id. (explaining that FDA chooses to administer guidance to inform
consumers and manufacturers of which apps the agency plans to
apply its authority over).
121. But see Cortez, supra note 100, at 1206 (“[N]otwithstanding this
boilerplate, few people understand FDA guidance documents as
being so impotent”).
122. U.S. FOOD & DRUG ADMIN., POLICY FOR DEVICE SOFTWARE
FUNCTIONS AND MOBILE MEDICAL APPLICATIONS: GUIDANCE FOR
INDUSTRY AND FOOD AND DRUG ADMINISTRATION STAFF (2017),
available
at
https://www.fda.gov/media/80958/download
[https://perma.cc/LNH3-5ND5].
123. In addition to the FTC and the FCC, several other federal
agencies—the Department of Defense, the Department of
Agriculture—exercise oversight also over telehealth—and
potentially over medical apps. Their regulations, however, are
specific to their areas of governance and I therefore omit them from
this analysis. See OFF. OF THE NAT’L COORDINATOR FOR HEALTH
INFO. TECH., FEDERAL TELEHEALTH COMPENDIUM 16–17 (Nov.
2016), available at https://www.healthit.gov/sites/default/files/
federal_telehealth_compendium_final_122316.pdf [https://perma
.cc/8C2Z-KKU9].
124. 15 U.S.C. §§ 41−58 (2018).
125. Mobile Health Apps Interactive Tool, FED. TRADE COMM’N,
https://www.ftc.gov/tips-advice/business-center/guidance/mobile
-health-apps-interactive-tool [https://perma.cc/Z8L8-K2B7] (last
visited Feb. 18, 2020) [hereinafter Mobile Health Apps].
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Tele-MAiD for MAiD ever appear on the FTC’s radar, that
agency would likely focus on the patient’s privacy and the
security of their identifiable-health information.126
With respect to the first aspect of the FTC’s oversight, TeleMAiD would not present a heightened risk to the security of the
patient’s privacy compared to other mobile medical apps already
on the market.127 And Tele-MAiD’s functionality, which merely
facilitates the communication between the patient and the
doctors, would not be harmful in the statutory sense.128 By the
same token, as long as the app is not presented as a “selfdiagnosing” tool, it is unlikely to mislead patients and doctors
regarding its intended use and limited capabilities.
In contrast with the FDA and FTC, who focus primarily on
concrete mobile health apps, the Federal Communications
Commission’s regulatory authority appears to be more general.129
The FCC regulates radio frequencies used by mobile network
operators, which would be integral to the proper functioning of
Tele-MAiD, that rely of broadband-internet service to connect
patients and doctors. In this regard, the FCC’s stance toward
regulating broadband-internet access can be of immense
significance for any mobile health app—including the ones for
MAiD. As of 2019, the FCC’s documents strongly suggest that
the agency is very interested in maximizing the potential of
broadband in health information technologies, including mobile
health, electronic health records, and consulting patients.130 At
the same time, the agency is yet to issue concrete regulatory
126. Cortez, supra note 100, at 1211.
127. See Iryna Pototska, HIPAA Requirements and Other Regulations
Imposed on Medical Software, YOLANTIS, https://yalantis.com
/blog/what-hipaa-requirements-apply-to-medical-appdevelopment/ [https://perma.cc/65P6-PKSN] (last visited Oct. 10,
2019).
128. Mobile Health Apps, supra note 126.
129. Connecting Americans to Health, FED. COMMC’NS COMM’N,
https://www.fcc.gov/about-fcc/fcc-initiatives/connectingamericans-health [https://perma.cc/VA44-ZXHB] (last visited
Oct. 10, 2019).
130. See generally FED. COMMC’NS COMM’N, CONNECTING AMERICA: THE
NATIONAL BROADBAND PLAN 200−202 (2010) (describing the
potential of applying broadband internet−based information
technologies in health care, including electronic health records,
remote patient monitoring, video consultations, etc.).
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policies applicable to mobile apps.131 The agency’s enthusiasm,
however, indicates low risks for developers, doctors, and patients
who intend to use mobile health apps relying on broadband
internet connection.
This analysis demonstrates that doctors do not face a higher
risk of legal liability for using the MAiD app, which conceivably
could fall under the category of Class two medical devices.
Furthermore, the current general attitude of regulatory agencies
creates a relatively friendly environment for mobile health app
developers.
C. Dispensation of Controlled Substances

In the United States, the medications typically prescribed to
qualifying patients for MAiD are secobarbital and
pentobarbital.132 Both drugs are potent barbiturates used in
anesthesia and have been designated as controlled substances by
the federal government in all states where MAiD is now legal.133
This designation is significant because controlled substances are

131. But see Connecting Americans to Health, supra note 130
(highlighting the FCC’s August 2019 “Report and Order to
strengthen its Rural Health Care Program by increasing
transparency, predictability, and efficiency of program funding
decisions” and support telehealth).
132. Bryant, supra note 20, at 715 (“Sodium pentobarbital and
secobarbital are short-acting barbiturates ideally suited for aid-indying statutory purposes because it is feasible to consume as a
single dose the quantity necessary to rapidly produce sleep,
followed by a fatal effect that occurs easily and relatively quickly
after ingestion.”) (footnote omitted). State reports also suggest that
other MAiD drugs include phenobarbital, morphine sulfate, and a
combination phenobarbital and chloral hydrate. WASH. 2017 REP.,
supra note 26; OR. 2017 DATA SUMMARY, supra note 9.
133. Both federal and state laws designate secobarbital and
pentobarbital as Schedule II substances, meaning that while they
have an approved medical use, they are also dangerous and have a
high potential of abuse. See 21 C.F.R. § 1308.12(e) (2018); CAL.
HEALTH & SAFETY CODE §§ 11055(e)(2), (4) (West 2018); COLO.
REV. STAT. §§ 18-18-204(2)(d)(II), (IV) (2018); D.C. CODE § 48902.06(4)(C),(D) (2013); HAW. REV. STAT. §§ 329-16(d)(3),(5)
(2017); MONT. CODE § 50-32-224(4)(c), (e) (2019); OR. REV. STAT.
§ 475.005(6)(a) (2017); VT. STAT. ANN. tit. 18, §§ 4201(6), (29)
(2015); WASH. REV. CODE § 69.50.101(e) (2017).
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subject to stricter rules regarding their dispensation (including
prescription and delivery) compared to other drugs.134
Still, the state statutes legalizing MAiD specifically authorize
attending physicians to prescribe MAiD medication to qualifying
patients or to deliver that medication directly to them.135
Furthermore, the Supreme Court has held that federal authorities
cannot interfere with this process simply because they believe
that MAiD is not a legitimate medical treatment option.136 TeleMAiD, however, presents the separate issue of whether an
attending physician can dispense MAiD medication to the patient
or his proxy if she has not examined that patient in the patient’s
“physical presence” or “in-person.”137 This issue―which concerns
only in-state prescribing―is regulated by both federal and state
law.
Under federal law, “[n]o controlled substance . . . may be
delivered, distributed, or dispensed by means of the [i]nternet
without a valid prescription”—that is, a prescription “issued for
a legitimate medical purpose in the usual course of professional
practice by a practitioner who has conducted at least [one] inperson medical evaluation of the patient.”138 “In-person
evaluation,” in turn, means “a medical evaluation that is
conducted with the patient in the physical presence of the
practitioner, without regard to whether portions of the evaluation
are conducted by other health professionals.”139 So, in order for
an attending physician to prescribe MAiD medication to the
qualifying patient, she will need to have evaluated the patient “in
person” at least once.
For patients who have not been examined “in person,” the
regulations provide for an option to be prescribed MAiD
medication “by a practitioner engaged in the practice of
134. See Controlled Substances Act, Pub. L. No. 91-513, 84 Stat. 1292
(1970).
135. See, e.g., OR. REV. STAT. § 127.815(l) (2013); COLO. REV. STAT.
§ 25-48-106(l) (2018).
136. See Gonzales v. Oregon, 126 S. Ct. 904, 925 (2006).
137. I use the terms “physical presence” and “in person” throughout this
essay to denote a situation in which the patient’s body is in close
proximity to the doctor and the doctor can directly observe the
patient without using electronic communication.
138. 21 U.S.C. § 829(e)(1)–(2) (2018).
139. 21 C.F.R. § 1300.04(f) (2018).
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telemedicine.”140 That exception from the general “in-person”
evaluation rule, however, is extremely narrow. To qualify for it,
the practice of telemedicine141 must fall under one of the seven
categories specified in the regulations, including telemedicine
conducted while the patient is admitted into a hospital or a clinic,
or while the patient is under the care of a physician registered to
dispense Schedule II controlled substances, like phenobarbital and
secobarbital.142 Theoretically, this gives qualifying terminal
patients who are treated by physicians unwilling to participate in
MAiD but registered to prescribe Schedule II controlled
substances an opportunity to obtain MAiD medication from
another physician who is willing to do so. This presents a
challenging ethical and legal question of whether or not the
unwilling physician could lodge a conscientious objection and
unilaterally terminate her doctor-patient relationship with the
qualifying patient based on his request for MAiD.143 This, in turn,
would likely terminate the willing physician’s eligibility to

140. 21 U.S.C. § 829(e)(3)(A) (2018).
141. 21 C.F.R. § 1300.04(i) (2018) (“[T]he practice of medicine in
accordance with applicable [f]ederal and [s]tate laws by a
practitioner (other than a pharmacist) who is at a location remote
from the patient and is communicating with the patient, or health
care professional who is treating the patient, using a
telecommunications system.”).
142. 21 C.F.R. §§ 1300.04(i)(1)–(2) (2018) (listing several other
categories, such as telemedicine encounters during a public health
emergency or the Department of Veteran Affairs medical
emergency, telemedicine practiced by an employee of Indian health
services, or telemedicine practiced pursuant to a special
registration); 21 C.F.R. §§ 1300.04(i)(3)−(7) (2018); See Nathaniel
M. Lacktman, Telemedicine Prescribing of Controlled Substances:
The Dark Side of the New Congressional Bill, HEALTH
CARE L. TODAY
(Apr. 29, 2018),
https://www.healthcarelaw
today.com/2018/04/29/telemedicine-prescribing-of-controlledsubstances-the-dark-side-of-the-new-congressional-bill/
[https://
perma.cc/324D-KF7Y] (describing an initiative in Congress
“intended to ‘light a fire’ and require the [Drug Enforcement
Administration] to promulgate interim final regulations [on special
registration for telemedicine] no later than [ninety] days after the
bill is enacted.”).
143. See John Y. Rhee et al., A Medical Student Perspective on
Physician-Assisted Suicide, 152 CHEST J. 475 (2017).
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prescribe her with the MAiD medication.144 In practice, however,
it appears more preferable for both qualifying patients and their
attending physicians to conduct an “in-person” examination of
the patient before the patient’s access to MAiD is inhibited. In
Part IV, I discuss this restriction from a normative perspective,
including whether it can find support in concerns similar to those
expressed in the context of “pill mills” for opioid prescriptions.145
In addition to federal rules, attending physicians who
dispense controlled substances also are subject to state statutes
and regulations. In some states, those regulations closely follow
the federal approach. For example, in Hawaii, the statute
provides that “[i]t shall be unlawful for any [physician] to
administer, prescribe, or dispense any controlled substance
without a bona fide physician-patient relationship.”146 For that
relationship to exist, “the treating physician or the physician’s
designated member of the health care team, at a minimum
shall . . . [p]ersonally perform a face-to-face history and physical
examination of the patient . . . .”147 A similar restriction exists in
Vermont, where “a health care provider . . . may prescribe,
dispense, or administer drugs . . . after having performed an
appropriate examination of the patient “in person,” through
telemedicine, or by the use of instrumentation and diagnostic
equipment through which images and medical records may be
transmitted electronically.”148 At the same time, the Vermont
statute regulating MAiD provides that the attending physician
must determine that the patient requesting MAiD “was suffering
a terminal condition, based on the physician’s physical
examination of the patient and review of the patient’s relevant
144. This situation could also present the question whether the first
doctor (who enables the patient to get the MAiD medication from
the doctor who provides MAiD through telemedicine) would be
eligible for compensation under the federal health insurance
programs such as Medicare.
145. See, e.g., Alene Kennedy-Hendricks et al., Opioid Overdose Deaths
and Florida’s Crackdown on Pill Mills, 106 AM. J. PUB. HEALTH
291 (2016) (discussing “‘pill mills,’ a category that includes
physicians, pain clinics, and other providers that dispense large
quantities of prescription drugs, typically for cash only, outside the
scope of standard medical practice.”).
146. HAW. REV. STAT. § 329-41(b) (2009).
147. HAW. REV. STAT. § 329-1 (2016).
148. VT. STAT. ANN. tit. 18 § 9361(b) (2017).
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medical records.”149 When faced with this apparent conflict
between the two statutes, physicians in Vermont are likely to
comply with the more restrictive rule of (arguably) a lex specialis
statute applicable to MAiD.
In other states, local rules appear to be more open toward
MAiD via telemedicine. At the same time, the state medical
boards and similar institutions charged with enforcement of
medical-care-quality standards may limit a physicians’ ability to
prescribe MAiD medications to qualifying patients whom they
have not examined in their “physical presence.” For example, in
California, the relevant statute provides that “[n]o person or
entity may prescribe, dispense, or furnish . . . dangerous
drugs . . . on the [i]nternet for delivery to any person in
[California], without an appropriate prior examination and
medical indication.”150 The language of this provision does not
refer to an “in-person” examination. However, the Medical Board
of California, which enforces these regulations, explained that
“[i]n-person examinations not only enhance the opportunity to
confirm if a patient needs the identified medication or to rule out
other medical conditions, but ensures the patient is advised of
alternative treatment options and is aware of potential side
effects.”151 Notably, the Medical Board of California did not rule
out the possibility that a doctor, who, for instance, would follow
her patient via Tele-MAiD and record her observations and the
patient’s diagnosis and prognosis in that manner, would
necessarily violate the appropriate prior examination standard.
An argument can also be made that under this scenario, the
attending physician “is able to conduct a bona fide medical
evaluation of the patient at the remote location, and is otherwise
acting in the usual course of professional practice”152 in the same
manner that other telehealth providers do.
149. VT. STAT. ANN. tit. 18 § 5283(a)(5)(A) (2015).
150. CAL. BUS. & PROF. CODE § 2242.1(a) (West 2016) (emphasis
added).
151. Joan Jerzak, Internet Prescribing—Information for Physicians,
MED. BD. OF CAL. (Feb. 2004), http://www.mbc.ca.gov/
Licensees/Prescribing/Internet_Prescribing.aspx [https://perma
.cc/NS49-Q9W5].
152. Implementation of the Ryan Haight Online Pharmacy Consumer
Protection Act of 2008; Final Rule, 74 Fed. Reg. 15,603 (Apr. 6,
2009) (to be codified at 21 C.F.R. pts. 1300, 1301, and 1304).
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In some states, medical boards appear to be more permissive.
For example, in Washington, the state Medical Quality Assurance
Commission in its “Appropriate Use of Telemedicine” guideline
states that a “ [t]elemedicine practitioner may provide any
treatment deemed appropriate for the patient, including
prescriptions, if the evaluation performed is adequate to justify
the action taken.”153 This standard, which emphasizes the
existence of a valid, bona fide doctor-patient relationship, appears
more sympathetic toward prescribing MAiD medications to
qualifying patients followed and evaluated via telemedicine154
than does California’s.
This analysis demonstrates that an attending physician who
has not examined a patient “in person” can prescribe MAiD
medication to that patient only under limited circumstances.
Under federal law, the patient must either be treated by another
physician authorized to dispense phenobarbital or secobarbital,
or be admitted to a hospital or a clinic that has the same
authorization.155 In the alternative, the attending physician must
have examined the patient in-person at least once before the
patient requested MAiD. In any event, a prescription of seco- or
pentobarbital to a qualifying patient without an in-person
examination is likely to be a red flag for the Drug Enforcement
Agency,156 which can bring criminal charges against the physician
and further impede the patient’s access to MAiD via
telemedicine.157 In addition, state medical boards can exercise
153. WASH. MED. QUALITY ASSURANCE COMM’N, APPROPRIATE USE OF
TELEMEDICINE
(GUIDELINE)
4
(2014),
available
at
https://wmc.wa.gov/sites/default/files/public/documents/
MD201403TelemedicineGuideline_approved10-3-14.pdf [https://
perma.cc/T52Q-5PJJ].
154. See Ancier v. Dep’t of Health, 166 P.3d 829, 831 (Wa. App. Ct.
2007) (explaining that the practice of prescribing medications over
the internet constituted unprofessional conduct where the
interaction between the doctor and his patients was limited to
reviewing the questionnaires filled out by the patients on the
internet).
155. Dispensing and Purchasing Controlled Substances over the
Internet, 66 Fed. Reg. 21181–21184 (2001).
156. See U.S. v. Rosen, 582 F.2d 1032, 1036 (5th Cir. 1978) (stating that
the absence of a physical examination is an example of “condemned
behavior”).
157. See, e.g., Press Release: Doctor charged for prescribing narcotics
to non-patients and ordered detained until trial, U.S. DRUG ENFM’T
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their discretion while enforcing rules of medical practice on
physicians, and in some states, doctors are expressly prohibited
from dispensing controlled substances to patients without an “inperson” examination.158 That aspect of prescribing controlled
substances to patients evaluated only telemedically is closely tied
to another facet of the legality of MAiD via telehealth: the
regulation of practice of medicine.
D. Regulation of Practice of Medicine

Medical professionals who provide MAiD via telehealth are
subject to regulations of medical practice. Those regulations can
be general (such as accepted standards of medical care) and
specific (such as pertaining to the regulation of MAiD and
telemedicine). Such regulations are enacted primarily at the state
level because it is the states that exercise the general police power
of protecting the well-being of their citizens, and one of the facets
of that power is the authority to regulate the medical profession
via state medical boards.159 There are also norms relevant to the
practice of medicine enacted at the federal level. Those federal
norms fall into two large groups. First, they establish important
rules about how the states and medical boards may or may not
exercise their police power.160 These “meta-level” rules provide for
ADMIN. (Mar. 20, 2019), https://www.dea.gov/press-releases/
2019/03/20/doctor-charged-prescribing-narcotics-non-patientsand-ordered-detained [http://perma.cc/ZT3P-5HA6].
158. CTRS. FOR DISEASE CONTROL AND PREVENTION, PRESCRIPTION
DRUG PHYSICAL EXAMINATION REQUIREMENTS (2015), available at
https://www.cdc.gov/phlp/docs/pdpe-requirements.pdf
[https://perma.cc/72NC-5M69].
159. Gabriel Scheffler, Unlocking Access to Health Care: A Federalist
Approach to Reforming Occupational Licensing, 29 HEALTH
MATRIX: J. L. MED. 293, 306 (2019).
160. See, e.g., Dent v. W. Va., 129 U.S. 114, 123 (1889) (“Due
consideration, therefore, for the protection of society may well
induce the state to exclude from practice those who have not such
a license, or who are found upon examination not to be fully
qualified.”); Williamson v. Lee Optical of Okla. Inc., 75 S.Ct. 461,
487–88 (1955) (holding that state regulations of medical practice
are subject to rational basis review if their constitutionality is
challenged); See N.C. St. Bd. of Dental Examiners v. F.T.C., 135
S. Ct. 1101, 1117 (2015) (holding that where state government
exercises no supervisory power over board of dentistry’s regulatory
activity, the board is not immune from antitrust proceedings).
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checks on how the states can regulate medical practice by
enacting their first-order regulations.161 Second, federal
authorities enact rules that both fall under the enumerated power
of the federal government and are relevant to the practice of
medicine.162 These rules can be of immense importance. For
example, 42 U.S.C. § 14401, which prohibits the use of federal
funds in connection with MAiD, means that federal insurance
programs like Medicare and Medicaid are unavailable to cover the
expenses of the patients who obtain MAiD.163
State regulations, however, impact the practice of medicine
more deeply. Those regulations, as relevant to providing MAiD
telemedically, cover three areas: (1) professional licensure; (2)
regulation of telemedicine; and (3) the practice of MAiD. With
respect to professional licensure, in all states where MAiD is
available to qualifying patients, telehealth is not considered a
separate form of medical practice; it is rather deemed “a
legitimate means by which an individual may receive health care
services from a health care provider without in-person contact
with the health care provider.”164 Accordingly, a physician who
wishes to provide medical treatment―including MAiD―via
telemedicine does not need to obtain a special license in addition
to the general license that she already has.
A common issue at the intersection of licensing and
telemedicine is the availability of interstate licensure for doctors
who reside in one state and wish to provide medical care
telemedically to patients in other states.165 This issue, as
important as it is, currently does not have much traction in the
161. N. C. St. Bd. of Dental Examiners v. F.T.C., 135 S.Ct. 1101, 1108–
09 (2015).
162. 42 U.S.C. § 14401 (2018) (“Federal funds may not be used to pay
for items and services [including assistance] the purpose of which is
to cause [or assist in causing] the suicide, euthanasia, or mercy
killing of any individual.”).
163. See id.
164. CAL. WELF. & INST. CODE § 14594(b) (West 2013); Accord COLO.
REV. STAT. §§ 10-16-123(2)(h)(4)(e)(I)–(II) (2018); D.C. CODE
§ 31-3861(4) (2013); HAW. REV. STAT. § 453-2(b) (2017); MONT.
CODE § 37-3-102(14) (2019); OR. REV. STAT. § 442.015(27) (2018);
VT. STAT. ANN. tit. 8 § 4100k(h)(7) (2017); WASH. REV. CODE
§ 70.41.020(13) (2016).
165. See generally, Legal Impediments to the Diffusion of Telemedicine,
14 J. HEALTH CARE L. & POL’Y 1, 9–10 (2011).
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MAiD context, because now doctors are allowed to provide MAiD
only to patients who reside in the state where they are licensed.166
For example, if a doctor residing and licensed in Colorado wishes
to provide MAiD telemedically to the residents of California, then
she must first get her Californian medical license and move to
that state. Otherwise, the patient would be unable to get MAiD
medication from his pharmacist in California under the
prescription written by the doctor from another state, and
California can initiate criminal proceedings against the doctor
from Colorado for unauthorized practice of medicine.167 There are
efforts supported by a number of states to enter into an
interstate-medical-licensure compact, which would allow
physicians from one state to get a medical license in another state
via an expedited procedure.168 Unfortunately, as of January 2019,
only three states where MAiD is legal (Colorado, Montana, and
Washington) have entered this arrangement,169 and despite that,
the compact has had seemingly no impact on the practice of
MAiD. In order for these compacts to make a difference, MAiD
statutes in the states that allow this practice must change in order
to create uniformity. If they do not change, or if more of those
states do not join the compact, then the compact will have no
impact on MAiD. The normative aspects of this issue are
discussed in depth in Part IV.
The second area of state regulation of medical practice—
delivery of medical care via telemedicine—has been the focus of
state-medical boards for a number of years.170 Despite the breadth
of such works, my research has not uncovered a single statement
from any board of medicine on the issue of providing MAiD
through telehealth. Still, some relevant information can be
gleaned from the boards’ approaches to the issue’s close cousin ―
166. See COLO. REV. STAT. § 25-48-103(1) (2018).
167. C.f. Stacey Swatek Huie, Facilitating Telemedicine: Reconciling
National Access with State Licensing Laws, 18 HASTINGS COMM.
AND ENT. L. J. l 377, 398 (1995).
168. Eric Wicklund, Telemedicine Licensure Compact is Now Live in
Half the Country, MHEALTH INTELLIGENCE (Jan. 10, 2019), https://
mhealthintelligence.com/news/telemedicine-licensure-compact-isnow-live-in-half-the-country [https://perma.cc/U4XA-YF5R].
169. COLO. REV. STAT. § 24-60-3602 (2018); MONT. CODE § 37-3-356
(2015); WASH. REV. CODE 18.71B (2017).
170. Wicklund, supra note 169.
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prescribing controlled substances via internet. In this regard,
medical boards appear to have taken the general approach that
in-person medical examinations remain the golden standard of
interaction with the patient to form a valid doctor-patient
relationship.171 Accordingly, telemedicine is evaluated in terms of
whether such a relationship was established. Considering our
hypothetical Tele-MAiD app from before, its protocol appears to
satisfy that criteria. This is especially true in light of federal
regulations, according to which a doctor can prescribe a patient
with a Schedule II controlled substance after at least one inperson examination.
Finally, one must consider whether the statutes legalizing
MAiD impose any restrictions on delivering that medical
treatment through telemedicine. As mentioned earlier, the most
telehealth-averse state in this respect is Vermont, where the
attending physician must perform at least one “in-person”
medical examination of a patient requesting MAiD, and the
patient, in turn, must request MAiD during a face-to-face
encounter with the attending physician.172 While other states do
not impose this requirement, their statutes do suggest that there
should be an established physician-patient relationship between
the individual requesting MAiD and the attending physician,
which traditionally is understood to be created by a face-to-face
encounter between the patient and the doctor.173 Only Hawaii has
expressly provided that the mental health specialist counseling to
establish the patient’s (in)eligibility for MAiD can be provided
through telehealth.174
This Part analyzed whether a medical professional who
wishes to provide MAiD services via telehealth might face
additional legal obstacles in that endeavor. I outlined four areas
where such hurdles could emerge: (1) privacy of the patients, (2)
requirements to medical devices, (3) dispensation of medication
without having examined the patient “in person,” and (4)
standards of medical practice. The first two areas present no
171. See e.g. Jerzak, supra note 152.
172. See VT. STAT. ANN. tit. 18, § 5283 (2015)).
173. See Kiek Tates et al., The Effect of Screen-to-Screen Versus Faceto-Face Consultation on Doctor-Patient Communication: An
Experimental Study with Simulated Patients, 19 J. MED. INTERNET
RES. (2017).
174. HAW. REV. STAT. § 327L-1 (2019).
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significant additional risks for medical professionals, as long as
our hypothetical app, Tele-MAiD, properly protects the patients’
data and entered the market after a premarket notification to the
FDA; the app’s developers do not make false or misleading claims;
and, both doctors and patients correctly understand the app’s
functions. The biggest obstacles reside in the third area, the
prescription of controlled substances, where the regulations
operate under the age-old assumption of “in-person” medical
evaluation being the hallmark of a valid doctor-patient
relationship. The same assumption also animates the attitudes of
some state medical boards toward telemedicine and presents a
normative objection to the digitalization of MAiD. These
obstacles are not insurmountable. In the next and final part, I
probe the soundness of the normative claims underlying that
assumption.

IV. Tele-MAiD and Doctor-Patient Relationship
Up to this point, my analysis of providing MAiD via
telehealth has been descriptive: I outlined the MAiD protocol, the
state of clinical practice, and law to determine whether it is
feasible to improve access to MAiD by offering it via the app.
Having answered that question in the affirmative, I now turn to
a different inquiry: whether we should permit physicians and
patients to access MAiD via telehealth.
Initially, MAiD might seem to be an unlikely candidate for
delivery through telemedicine because of the impact it has on the
patient’s quality of life and because of the potential difficulty of
creating a valid doctor-patient relationship, accurately evaluating
a patient, and meticulously adhering to the standard of care. On
closer look, however, that standard of care is reflected in the
MAiD protocol prescribed by state law, and following it addresses
some of the concerns typically raised about telehealth (such as
informed consent, confidentiality, record-keeping, and mitigation
of a possible harm to the patient).175
The remaining normative objection to the digitalization of
MAiD appears to concern the possibility of establishing a valid
doctor-patient relationship by telehealth. In regulatory realms,
this objection manifests itself as the requirement that the
175. See, e.g., B.M. Dickens & R.J. Cook, Legal and Ethical Issues in
Telemedicine and Robotics, 94 INT’L. J. GYNECOLOGY &
OBSTETRICS 73, 77 (2006).
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attending physician must perform an “in-person” medical
examination of the patient before prescribing him with a lethal
dose of medication.176 But is this a sound objection?177 I conclude
that the objection fails to keep pace with evolving technology and
suggest that the “in-person”-examination requirement should be
modified.
MAiD requires an “in-person” examination of the requesting
patient by his attending physician. This requirement is either
spelled out in the applicable state statutes or follows from the
federal law on prescription of controlled substances.178 The “inperson” examination traditionally is understood, for purposes of
this requirement, as an examination performed by a doctor who
is in close spatial proximity to the patient’s body. By contrast,
the premise of telemedicine is that certain medical interactions
do not require face-to-face contact.179 Furthermore, telemedicine
invites us to reevaluate the traditional approach to “in-person”
examination in providing MAiD.
Rethinking this traditional approach bifurcates into two lines
of inquiry: whether it makes sense to demand that an “in-person”
examination must involve the patient’s body being in close
proximity to the doctor; and whether the traditional approach is
the only means of establishing a valid doctor-patient relationship
for purposes of MAiD. Answering both of these questions in the
176. VT. STAT. ANN. tit. 18, § 5283(a)(5)(A) (2013); WASH. REV. CODE
§ 70.245.040(1(a) (2009).
177. Pairing MAiD and telehealth also evokes several other normative
issues related to the practice of MAiD, such as the soundness of the
patient’s residency requirement and the appropriateness of spelling
out the standard of care for MAiD in a statute. Because these issues
are not directly relevant to the topic of this section, I leave their
discussion for another essay.
178. For purposes of this section, I bracket out an exception from the
federal law requirement, under which a doctor can prescribe a
patient with a Schedule II substance if the doctor has not examined
the patient in person and the patient is being treated by another
practitioner or is admitted into a hospital or a clinic.
179. See The Ultimate Telemedicine Guide | What Is Telemedicine?,
EVISIT (May 25, 2018), https://evisit.com/resources/what-istelemedicine/ [https://perma.cc/VH78-KHS3]; See also Shivan J.
Mehta, Telemedicine’s Potential Ethical Pitfalls, AMA J. ETHICS
(Dec.
2014),
https://journalofethics.ama-assn.org/article
/telemedicines-potential-ethical-pitfalls/2014-12 [https://perma.cc
/D9F2- FSKF].
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negative would mean that the traditional approach is inapplicable
in telemedicine and that MAiD should be extended to telehealth.
To answer the first question, consider a series of three short
hypotheticals. First, a physician prepares to treat a patient who
suffers from a highly contagious disease with an unknown
infection mechanism. In order to protect the doctor from the
disease, she and her patient are placed in the same room but are
separated by a translucent wall of very thick glass. Both are
positioned in close proximity to the wall; the distance between
them is about two feet. The doctor and the patient can see and
hear each other (there are sound amplifiers in both parts of the
room) but they cannot smell or touch each other. The doctor
examines the patient by asking him to perform certain actions—
opening his mouth, coughing, flexing his limbs—and to use
certain medical devices located on the patient’s side of the room
(such as using a smartphone with an extension that turns it into
a stethoscope). In this hypothetical, has the doctor performed an
“in-person” examination of the patient?
Second, imagine the same hypothetical as above, except, in
this case, the doctor and the patient are separated not by a wall
of glass, but by a wall with a big digital screen with the digital
images of the patient and the doctor. The screen is connected to
high-resolution cameras that allow them to watch each other’s
actions in real time. Furthermore, the doctor can zoom in and out
on the image of the patient. Has the doctor performed an “inperson” examination of the patient?
Finally, consider the second hypothetical, except the doctor
is sitting in front of a screen on his laptop, and the patient is one
thousand miles away from the doctor. Everything else—the realtime response, the sound and audio fidelity, the zooming
capabilities—has not changed. Has the doctor performed an “inperson” examination of the patient?
If you have answered the question in the first hypothetical in
the affirmative, then I submit that you logically will answer the
subsequent questions affirmatively as well. While there are
distinctions between those scenarios, they are without a difference
for purposes of determining whether an “in-person” examination
took place. In the first and second hypotheticals, the doctor and
the patient are in close spatial proximity to one another and
interact with each other directly; however, they cannot touch
each other. The fact that in these scenarios they are separated by
different kinds of walls cannot justify the purported difference in
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the nature of examination. In the second and third hypothetical,
the only difference is the size of the screen and the distance
between the doctor and the patient. If we posit that the doctor
examined the patient in person in the second encounter, then
those differences also are insignificant to determine the nature of
their encounter in the third hypothetical.
I argue that the affirmative answer to the first hypothetical
is the correct one. This is because the physical presence of the
patient before the doctor―which is what the “in-person” standard
demands―can manifest itself in various ways. While the spatial
proximity between the doctor and the patient’s body certainly is
one way to establish this connection, it is not the only one. From
a scientific perspective, the patient’s image, voice, and health
data shared with his doctor are undeniably physical. If that is the
case, then the physical presence for the purpose of the “in-person”
examination can be established by means of electronic
communication.180
Consistency and science, however, often give way to policy
considerations when law is concerned.181 In this respect, the “inperson” examination requirement may not be met, as a matter of
policy, when the physician and the patient use electronic
communication. Such situations could emerge, for example, in the
instance of the patient’s disease the diagnosis of which involves
touching or smelling the patient by the doctor, which, as of today,
are incapable of being performed electronically.182 For MAiD
180. This is not to say, of course, that electronic communication is
sufficient to establish physical presence in every context. For
example, in a boxing match, physical presence demands spatial
proximity between the competing athletes because of the purpose
of the tournament. The purposes of a doctor-patient
relationship―building trust and providing medical care―can be
served by electronic communication. See 50-state survey:
Establishment of a patient-physician relationship via telemedicine,
AM. MED. ASS’N, https://www.ama-assn.org/system/files/201810/ama-chart-telemedicine-patient-physician-relationship.pdf
[https://perma.cc/W7WP-LLK8] (last visited Sept. 20, 2019).
181. See, e.g., Nix v. Hedden, 13 S.Ct. 881, 882 (1893) (“Botanically
speaking, tomatoes are the fruit of a vine, just as are cucumbers,
squashes, beans, and peas. But in the common language of the
people, whether sellers or consumers of provisions, all these are
vegetables . . . .”).
182. With respect to touching, however, one could imagine Tele-MAiD
first directing the patient to put his smartphone on a certain part
of his body, then causing the device to vibrate in a manner
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provided via telemedicine, this means that the need for an “inperson” examination, as traditionally understood, remains for the
terminal diseases that cannot be accurately diagnosed without the
doctor touching and/or smelling her patient (or the patient’s
body excretions). In these limited situations, “the quality of the
remote physical examination is clearly inferior to the quality of
an in-person examination.”183 At the same time, as new
broadband internet-based technologies develop, the traditional
view of “in-person” examination faces the possibility of becoming
more and more obsolete. This new approach is also consistent
with efforts to expand the telemedicine exception for prescription
of controlled substances under federal law.184
The second line of inquiry outlined earlier asks whether a
telemedicine encounter between the doctor and patient is
sufficient to create a valid doctor-patient relationship.185 The
answer to this question may differ depending on the extent to
resembling the physician applying pressure to the patient’s body.
It would then register contractions of the patient’s body in response
to vibration and sends that data to the patient’s physician.
Ultrasonics—Medical Applications, ENCYC. BRIT., https://www.
britannica.com/science/ultrasonics/Medical-applications
[https://perma.cc/6M89-Y7YW] (last visited Feb. 19, 2020).
183. Dorsey & Topol, supra note 13, at 156.
184. Nathaniel M. Lacktman & Thomas B. Ferrante, Congress Proposes
Change to Ryan Haight Act to Allow Telemedicine Prescribing of
Controlled Substances, HEALTH CARE L. TODAY (Mar. 5, 2018),
https://www.healthcarelawtoday.com/2018/03/05/congressproposes-change-to-ryan-haight-act-to-allow-telemedicineprescribing-of-controlled-substances
[https://perma.cc/PH5RLN9A] (discussing initiatives in Congress to expand the
telemedicine exceptions from controlled substances law and noting
that the “exceptions are very narrow, highly technical, and simply
outdated. The practice of telemedicine has evolved . . . , and the
regulations fail to account for how legitimate telemedicine services
are delivered today. For that reason, the exceptions do not easily
align with direct-to-patient service models frequently sought by
patients in areas such as telepsychiatry or substance use disorder
treatment.”).
185. Of note, traditional in-person interactions between doctors and
patients can often result in shallow and profit-driven relationships,
too. Dorsey & Topol, supra note 13, at 156 (discussing how
telemedicine can “create shallow patient-physician relationships
that are based on transactions and undermine efforts to integrate
care.”).
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which the physician became involved with the health of her
patient.186 In the case of our hypothetical app, Tele-Maid, the
physician actively follows the patient and communicates with him
about his disease, maintains the patient’s electronic medical
record and shares it with her colleagues, diagnoses the patient
with a terminal illness and discusses the alternatives to MAiD at
length. The rigorous patient-evaluation process embedded in
MAiD treatment ensures that a meaningful doctor-patient
relationship exists and prevents the practice from devolving into
a “drive-through” variety of medicine, which is characteristic of
opioid “pill mills.”187 Furthermore, the depth and the scope of
that interaction and communication might be higher than in a
typical twenty-minute face-to-face encounter with a physician in
a clinic. Therefore, it should be deemed sufficient to establish a
valid, lasting doctor-patient relationship, with all rights and
duties of provider and her patient that follow from it.188 While
the state boards of medicine, as described earlier, are
understandably cautious about unscrupulous providers who fail
to establish a meaningful doctor-patient relationship with their
clients, this relationship is present when MAiD is provided
telemedically.

Conclusion
Telemedicine has the potential to improve access to many
medical treatments, including MAiD. I argue that a hypothetical
app—called Tele-MAiD here—could make MAiD more accessible
to qualifying patients and cost less to the health care system than
current options. At the same time, it is critical to ensure that the
quality of MAiD as a medical treatment is the same regardless of
186. See, e.g., John D. Blum, Internet Medicine and the Evolving Legal
Status of the Physician-Patient Relationship, 24 J. LEGAL MED. 413,
414 (2003) (discussing various online activities of doctors and
patients and whether those activities can establish the doctorpatient relationship).
187. Khary K. Rigg et al., Prescription Drug Abuse & Diversion: Role
of the Pain Clinic, 40 J. DRUG ISSUES 681, 686–88 (2010).
188. Blum, supra note 187, at 437 (“While the physician-patient
relationship is one that traditionally emerges from a face-to-face
encounter, the courts do not require physical presence as a
prerequisite for a legal relationship to be established between
physician and patient”).
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whether it is provided telemedically or in the traditional way. In
analyzing the clinical and legal aspects of providing MAiD via
telemedicine and exploring some normative questions that that
analysis evoked, I conclude that MAiD can be provided
telemedically to patients with readily and accurately diagnosableterminal illnesses. The largest legal obstacle to such
implementation is the requirement that the attending physician
conduct an “in-person” examination of the patient; this is so
because telemedicine challenges the traditional understanding of
an “in-person” examination. I suggest that that concept should
be expanded to encompass examinations conducted in real time
through modern means of electronic communication, such as
Tele-MAiD. Such communication establishes a valid doctorpatient relationship between the patient seeking MAiD and his
attending physician. Ultimately, these conclusions compel the
finding that MAiD by telehealth is not only feasible, but also
beneficial.
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